U.S. patent application number 14/951457 was filed with the patent office on 2016-03-17 for coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same.
The applicant listed for this patent is Ikeda Food Research Co., Ltd.. Invention is credited to Ayaka Atsumi, Emi Ishimaru, Tetsunari Morita, Hironori Omura, Hirokazu Sanada, Takako Yada.
Application Number | 20160076007 14/951457 |
Document ID | / |
Family ID | 37023885 |
Filed Date | 2016-03-17 |
United States Patent
Application |
20160076007 |
Kind Code |
A1 |
Omura; Hironori ; et
al. |
March 17, 2016 |
COENZYME-LINKED GLUCOSE DEHYDROGENASE AND POLYNUCLEOTIDE ENCODING
THE SAME
Abstract
The present invention provides members that produce on a large
scale a coenzyme-linked glucose dehydrogenase which has excellent
substrate-recognizing ability toward glucose while providing low
action on maltose. The present invention relates to a
polynucleotide encoding a soluble coenzyme-linked glucose
dehydrogenase that catalyzes the oxidation of glucose in the
presence of an electron acceptor and has an activity toward maltose
of 5% or lower; a polypeptide encoded by the nucleotide sequence of
the polynucleotide; a recombinant vector carrying the
polynucleotide; a transformed cell produced using the recombinant
vector; a method for producing a polypeptide comprising culturing
the transformed cell and collecting from the cultivated products a
polypeptide that links to FAD to exert the glucose dehydration
activity; a method for determination of glucose using the
polypeptide; a reagent composition for determination of glucose;
and a biosensor.
Inventors: |
Omura; Hironori;
(Hiroshima-ken, JP) ; Sanada; Hirokazu;
(Hiroshima-ken, JP) ; Yada; Takako;
(Hiroshima-ken, JP) ; Atsumi; Ayaka; (Tsukuba-shi,
JP) ; Morita; Tetsunari; (Hiroshima-ken, JP) ;
Ishimaru; Emi; (Hiroshima-ken, JP) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Ikeda Food Research Co., Ltd. |
Fukuyama-shi |
|
JP |
|
|
Family ID: |
37023885 |
Appl. No.: |
14/951457 |
Filed: |
November 24, 2015 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
14184573 |
Feb 19, 2014 |
|
|
|
14951457 |
|
|
|
|
11886885 |
Apr 1, 2008 |
8691547 |
|
|
PCT/JP2006/306198 |
Mar 27, 2006 |
|
|
|
14184573 |
|
|
|
|
Current U.S.
Class: |
435/188 |
Current CPC
Class: |
C12Q 1/004 20130101;
G01N 27/3271 20130101; C12Q 1/006 20130101; G01N 2333/904 20130101;
C12N 9/0006 20130101; C12Q 1/32 20130101; C12Y 101/05 20130101;
C12N 9/0004 20130101; C12Y 101/9901 20130101 |
International
Class: |
C12N 9/04 20060101
C12N009/04 |
Foreign Application Data
Date |
Code |
Application Number |
Mar 25, 2005 |
JP |
2005-089884 |
Claims
1-37. (canceled)
38. A method for producing a flavin adenine dinucleotide
(FAD)-linked glucose dehydrogenase (GLD) having a glucose
dehydrogenation activity, comprising: cultivating a transformed
host cell comprising a polynucleotide encoding the GLD, expressing
the GLD, and collecting the GLD, wherein the GLD catalyzes
dehydrogenation of glucose in presence of an electron acceptor and
has an activity toward maltose of 5% or less with respect to an
activity toward glucose, and the GLD has an amino acid sequence
comprising sequences of the coenzyme-linked glucose dehydrogenase
set forth in SEQ ID NOs. 8 to 12, wherein the polynucleotide is not
cDNA.
39. The method according to claim 38, wherein the GLD has a subunit
molecular weight of approximately 63 kDa, wherein the term "subunit
molecular weight" refers to a subunit molecular weight determined
by subjecting the GLD without sugar chains to polyacrylamide gel
electrophoresis (SDS-PAGE).
40. The method according to claim 39, wherein the GLD catalyzes a
reaction in which a hydroxyl group at a 1-position of glucose is
oxidized, and the glucose is converted to
glucono-.delta.-lactone.
41. The method according to claim 40, wherein the GLD catalyzes
dehydrogenation of glucose in presence of an electron acceptor.
42. A method for producing a flavin adenine dinucleotide
(FAD)-linked glucose dehydrogenase (GLD) having a glucose
dehydrogenation activity, comprising: cultivating a transformed
host cell comprising a polynucleotide encoding the GLD, expressing
the GLD, and collecting the GLD, wherein the polynucleotide
encoding the GLD comprises the sequences set forth in SEQ ID NOs. 5
to 7, and the GLD has the following properties (a) to (d): (a)
having a subunit molecular weight of approximately 63 kDa, wherein
the term "subunit molecular weight" refers to a subunit molecular
weight determined by subjecting the GLD without sugar chains to
polyacrylamide gel electrophoresis (SDS-PAGE); (b) utilizing a FAD
as a coenzyme; (c) catalyzing a reaction in which a hydroxyl group
at a 1-position of glucose is oxidized, and the glucose is
converted to glucono-.delta.-lactone; and (d) having an activity
toward maltose of 5% or less with respect to an activity toward
glucose, wherein the polynucleotide is not cDNA.
43. A method for producing a flavin adenine dinucleotide
(FAD)-linked glucose dehydrogenase (GLD) having a glucose
dehydrogenation activity, comprising: cultivating a transformed
host cell comprising a polynucleotide encoding the GLD, expressing
the GLD, and collecting the GLD, wherein the GLD catalyzes
dehydrogenation of glucose in presence of an electron acceptor and
has an activity toward maltose of 5% or less with respect to an
activity toward glucose, and the GLD includes: (a) an amino acid
sequence set forth in SEQ ID NO: 2 or an amino acid sequence set
forth in amino acids 20 to 592 of SEQ ID NO: 2; or (b) an amino
acid sequence with a homology of at least 90% to the amino acid
sequence set forth in SEQ ID NO: 2 or the amino acid sequence set
forth in amino acids 20 to 592 of SEQ ID NO: 2 wherein the
polynucleotide is not cDNA.
44. The method according to claim 38, wherein the GLD is derived
from a microorganism of an Aspergillus genus, Penicillium genus, or
Ganoderma genus.
45. The method according to claim 42, wherein the GLD is derived
from a microorganism of an Aspergillus genus, Penicillium genus, or
Ganoderma genus.
46. The method according to claim 43, wherein the GLD is derived
from a microorganism of an Aspergillus genus, Penicillium genus, or
Ganoderma genus.
47. The method according to claim 44, wherein the GLD is derived
from a microorganism of an Aspergillus terrous (A terrous).
48. The method according to claim 45, wherein the GLD is derived
from a microorganism of an Aspergillus terreus (A terreus).
49. The method according to claim 46, wherein the GLD is derived
from a microorganism of an Aspergillus terrous (A terreus).
Description
TECHNICAL FIELD
[0001] The present invention relates to a novel coenzyme-linked
glucose dehydrogenase (hereinafter, may be referred to as "GLD"), a
polynucleotide encoding the same, a method for producing the same,
a method for producing the GLD, and use of the GLD.
BACKGROUND ART
[0002] The glucose content in blood is considered an important
marker for diabetes. A diagnosis of diabetes is made by a
simplified measurement (Point-of-Care Testing: POCT) such as a
simplified test conducted by clinical staff or the like, or a
self-inspection conducted by a patient, in addition to a clinical
examination conducted in a hospital examination room or the
like.
[0003] Although the simplified measurement is conducted using a
glucose diagnostic kit or a measurement apparatus such as a
biosensor or the like (POCT apparatus), a glucose oxidase is
conventionally used in the POCT apparatus. However, the glucose
oxidase depends on dissolved oxygen concentration, and thereby
errors occur in measured values. Accordingly, use of glucose
dehydrogenase which is not influenced by oxygen is recommended.
[0004] There are, as the glucose dehydrogenase, NAD
coenzyme-unlinked glucose dehydrogenases of which the coenzyme is
nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine
dinucleotide phosphate (NADP) and coenzyme-linked glucose
dehydrogenases of which the coenzyme is pyrroloquinoline quinone
(PQQ), flavin adenine dinucleotide (FAD), or the like. Among them,
the coenzyme-linked glucose dehydrogenases are advantageous in that
they are less liable to be affected by contamination components in
comparison with the NAD coenzyme-unlinked glucose dehydrogenases,
and they realize high measurement sensitivity and production of the
POCT apparatuses at low cost.
[0005] However, conventional pyrroloquinoline quinone (PQQ)-type
glucose dehydrogenases are disadvantageous in that the stability
thereof is low, and they easily react with maltose or galactose.
Maltose is a sugar used in a transfusion. When the PQQ-type glucose
dehydrogenases react with maltose, the POCT apparatus which
measures blood sugar levels indicates a higher blood sugar level
than an actual blood sugar level. As a result, the patient injects
an excessive amount of insulin, and thereby suffers from
hypoglycaemia, which causes consciousness disorder or a comatose
state, which has attracted tremendous interest.
[0006] In particular, the blood sugar POCT apparatus is used to
measure the blood sugar level and the importance thereof has
increased due to its convenience in patient self-care and
medication, and thus self blood sugar monitoring apparatuses
(Self-Monitoring of Blood Glucose: SMB) have been increasingly used
in the home. Accordingly, the demand for realizing measurement
accuracy is deemed to be very high.
[0007] In actuality, a notification calling for attention with
respect to use of blood sugar testing apparatuses with an enzyme
that utilizes PQQ as a coenzyme was issued to patients receiving
maltose transfusion from the Japanese Ministry of Health, Labor and
Welfare on February, 2005 (Feb. 7, 2005; Pharmaceutical and Food
Safety Notification No. 0207005, and the like).
[0008] On the other hand, there have been reported, as the
coenzyme-linked glucose dehydrogenases which catalyze
dehydrogenation of glucose with FAD as the coenzyme, enzymes
originating from Agrobacterium tumefaciens (J. Biol. Chem. (1967)
242: 3665-3672), enzymes originating from Cytophaga marinoflava
(Appl. Biochem. Biotechnol. (1996) 56: 301-310), enzymes
originating from Halomonas sp. .alpha.-15 (Enzyme Microb. Technol.
(1998) 22: 269-274), enzymes originating from Agaricus bisporus
(Arch. Microbiol. (1997) 167: 119-125, Appl. Microbiol. Biotechnol.
(1999) 51: 58-64), and enzymes originating from Macrolepiota
rhacodes (Arch. Microbiol. (2001) 176: 178-186). These enzymes
oxidize a hydroxyl group at the 2-position and/or 3-position of
glucose, and exhibit a high activity toward maltose, but low
selectivity to glucose. Although coenzyme-linked glucose
dehydrogenases originating from Burkhorderia cepacia with a high
activity toward maltose are also known, their natural type enzyme
is a heterooligomer enzyme composed of three subunits .alpha.,
.beta., and .gamma., and known as a membrane-binding enzyme.
Accordingly, there are disadvantages in that solubilization
treatment is required to obtain the enzyme, and cloning of
necessary subunits is simultaneously required to realize sufficient
activity by cloning.
[0009] In the Society for Biotechnology, Japan (Oct. 28 to 30,
2002), there was a presentation regarding the substrate selectivity
(activity against maltose and activity against galactose, with
respect to the activity against glucose which is assumed to be
100%) in which SM4 strain exhibited 40% and 105%, JCM5506 strain
exhibited 43% and 132%, JCM550 strain exhibited 57% and 123%,
JCM2800 strain exhibited 83% and 108%, JCM2801 strain exhibited 74%
and 117%, IFO14595 strain exhibited 38% and 104%, and IFO15124
strain exhibited 74% and 148%, and the presenter thereof stated
that these strains exhibited high activity against maltose, which
was disadvantageous if used for a self blood sugar monitoring
apparatus, and therefore the presenter was going to improve the
substrate selectivity by changing the sequence thereof.
[0010] In contrast, inventors of the present invention invented a
novel soluble coenzyme-linked glucose dehydrogenase of which the
coenzyme is FAD and which is not a membrane-bound type, and filed a
patent application (Patent Document 1). The coenzyme-linked glucose
dehydrogenase disclosed in Patent Document 1 oxidizes a hydroxyl
group at the 1-position of glucose, is excellent in
substrate-recognizing ability against glucose, is not influenced by
dissolved oxygen, and exhibits low activity toward maltose
(activity against maltose of 5% or less and activity against
galactose of 5% or less, with respect to the activity against
glucose which is assumed to be 100%), such excellent
characteristics not being realized by conventional ones.
[0011] However, the coenzyme-linked glucose dehydrogenase disclosed
in Patent Document 1 is isolated or extracted from liquid culture
medium in which wild microorganisms (such as, for example,
microorganisms belonging to the genus Aspergillus) are cultivated,
and therefore, the production yield thereof is limited. In addition
to the slight production yield of the enzyme, large amounts of
sugar are bound to the enzyme, and therefore the enzyme is in a
so-called "sugar-embedded-type enzyme" from which is coated by
different kinds of sugar from N-type or O-type sugar chain which
binds to general enzymes, as a result of which the activity thereof
is difficult to be detected (that is, the enzyme activity is low),
the sugar chain cannot be removed enzymatically or chemically, and
thereby, the enzyme is scarcely stained by usual protein staining
(using Coomassie Brilliant Blue G-250 or the like) after
electrophoresis, and a terminal or internal amino acid sequence of
the enzyme, which is necessary information for obtaining the gene,
is difficult to decode by performing conventional purification.
Accordingly, there is no case in which cloning of the enzyme gene
succeeds to ascertain expression of the enzyme activity.
[0012] Although the existence of coenzyme-linked glucose
dehydrogenases originating from Aspergillus oryzae was suggested in
1967 (Non-patent Document 1), only partial enzymatic properties
thereof were revealed. Although the dehydrogenase was suggested to
provide no influence on maltose, there are no detailed reports
regarding the coenzyme-linked glucose dehydrogenases originating
from Aspergillus oryzae, and no reports regarding coenzyme-linked
glucose dehydrogenases originating from other microorganisms which
oxidize a hydroxyl group at the 1-position of glucose, and also no
reports regarding amino acid sequences or genes of the
coenzyme-linked glucose dehydrogenases are known.
[0013] Although an idea of measuring glucose using a glucose
dehydrogenase EC 1.1.99.10 is known (see Patent Document 15), there
is no case in which any coenzyme-linked glucose dehydrogenases are
produced to a practical level, and therefore, no coenzyme-linked
glucose dehydrogenases have been developed for practical use in a
sensor. The reason for this is the activity of the enzyme in the
fungus body is weak, and even if the enzyme is secreted outside the
fungus body, the amount thereof is extremely slight, and the
activity thereof is weak because the enzyme is coated by a large
amount of sugar, as a result of which the enzyme is difficult to
detect. Accordingly, it is speculated that a gene of the enzyme can
not be cloned.
[0014] It is been known that the measurement of glucose levels
using a sensor utilizing a glucose oxidase is influenced by sugar
chains of the enzyme, and thereby it is difficult for an enzyme
originating from molds rich in sugar chains to be adapted to the
glucose sensor (Non-patent Document 2). It is known, for example,
that solid cultivation of microorganisms belonging to the genus
Aspergillus increases the sugar content of yielded enzymes in
comparison with liquid cultivation thereof (Non-patent Document 3),
and thus it is known that solid cultivation generally increases
sugar chains in comparison with liquid cultivation. Thus, one of
reasons coenzyme-linked glucose dehydrogenases have not been
developed for practical use until now is assumed to be because it
has been difficult to reduce sugar chain contents of the glucose
dehydrogenases originating from molds to utilize it in a glucose
sensor even if cultivating conditions are investigated.
[0015] In fact, although the present inventors purified a
coenzyme-linked glucose dehydrogenase originating from Aspergillus
terreus, the inventors found that the obtained dehydrogenase was
coated with a great amount of sugars to be in a form which may be
called an "arabinogalactan embedded-type enzyme", as a result of
which an enzyme-immobilized electrode formed by applying the enzyme
on an electrode and then drying is not sufficiently dried, and the
reactivity of a glucose sensor is deteriorated by the existence of
the sugars.
[0016] Biogenetic methods in which gene stocks encoding proteins
such as enzymes or the like are utilized to produce the proteins on
a massive scale are known, and biogenetic methods for preparing
glucose dehydrogenases as disclosed in Patent Documents 2 to 14 are
known. These mainly relate to modification of PQQ glucose
dehydrogenases, and provide modified PQQ glucose dehydrogenases, in
which disadvantages of conventional PQQ glucose dehydrogenases,
such as low substrate selectivity and low stability, are improved,
and modified gene stocks for biogenetically preparing the modified
PQQ glucose dehydrogenases. [0017] [Patent Document 1]
WO2004/058958 Pamphlet [0018] [Patent Document 2] Japanese
Laid-Open Patent Application No. 2000-312588 [0019] [Patent
Document 3] Japanese Laid-Open Patent Application No. 2000-350588
[0020] [Patent Document 4] Japanese Laid-Open Patent Application
No. 2000-354495 [0021] [Patent Document 5] Japanese Laid-Open
Patent Application No. 2001-197888 [0022] [Patent Document 6]
Japanese Laid-Open Patent Application No. 2001-346587 [0023]
[Patent Document 7] Japanese Laid-Open Patent Application No.
2001-37483 [0024] [Patent Document 8] Japanese Laid-Open Patent
Application No. 2004-173538 [0025] [Patent Document 9] Japanese
Laid-Open Patent Application No. 2004-313172 [0026] [Patent
Document 10] Japanese Laid-Open Patent Application No. 2004-313180
[0027] [Patent Document 11] Japanese Laid-Open Patent Application
No. 2004-344145 [0028] [Patent Document 12] Japanese Unexamined
Patent Application, First Publication No. H10-243786 [0029] [Patent
Document 13] Published Japanese translation No. 2004-512047 of PCT
International Publication [0030] [Patent Document 14] WO2002/072839
Pamphlet [0031] [Patent Document 15] Japanese Unexamined Patent
Application, First Publication No. S59-25700 [0032] [Non-patent
Document 1] Biochem. Biophys. Acta., 139, 277-293, 1967 [0033]
[Non-patent Document 2] Appl Environ Microbiol., 64(4), 1405-1411,
1998 [0034] [Non-patent Document 3] Biosci. Biotechnol. Biochem.,
62(10), 1938-1946, 1998
DISCLOSURE OF THE INVENTION
Problems to be Solved by the Invention
[0035] However, in the case of the modified PQQ glucose
dehydrogenases prepared using the modified gene stocks, the degree
of activity toward maltose is approximately 10% or more, which is
high, with respect to the degree of activity toward glucose which
is assumed to be 100%. When the reactivity toward maltose is
lowered, the reactivity (specific activity) to glucose is also
lowered. Accordingly, when the activity is monitored by an
electrochemical measurement method under a condition in which the
content of substrate is sufficient, functions as a glucose sensor
are insufficiently exhibited, and practical application to POCT
apparatuses or the like has not been realized.
[0036] Also, there are disadvantages that a coenzyme PQQ required
for expressing activity of the PQQ glucose dehydrogenase is not
produced by Escherichia coli bacterium which is broadly used as a
recombinant host in general, and so the recombinant host thereof is
limited to host microorganisms that produce PQQ (such as, for
example, Pseudomonad).
[0037] The present invention has been achieved in view of the
above-mentioned problems of the prior arts, and has as its object
to provide: a coenzyme-linked glucose dehydrogenase, in which the
problems caused by the great deal of sugar bonded to the enzyme are
solved, and which has excellent characteristics such as an
excellent reactivity toward glucose, thermal stability, and
substrate-recognizing ability, and a low activity toward maltose; a
method for easily producing the coenzyme-linked glucose
dehydrogenase on a massive scale; a polynucleotide encoding the
dehydrogenase; a method for producing the polynucleotide; a method
for measuring glucose levels using the dehydrogenase; a reagent
composition for measuring the glucose levels; and a biosensor for
measuring the glucose levels.
Means for Solving the Problems
[0038] The inventors of the present invention considered that mass
production of a glucose dehydrogenase that does not act on maltose
needs to be realized at a practical cost by gene cloning, in
addition to a decrease of the content of the sugar chain massively
bonded to the dehydrogenase to an applicable level for measurement
of glucose, so that the coenzyme-linked glucose dehydrogenase is
broadly utilized for industrial application. Moreover, the
inventors considered that decoding of terminal or internal amino
acid sequences of the dehydrogenase and obtaining of information
necessary for obtaining the gene are essential for cloning the
gene, and therefore, removal of the great deal of sugar embedding
the dehydrogenase, different from general N-type or O-type sugar
chains, to improve the stainability of the protein as well as to
realize HPLC analysis, is required. Accordingly, the inventors have
earnestly investigated to obtain a purified dehydrogenase from
which the sugar embedding the dehydrogenase is removed, the sugar
making it difficult to perform protein staining and HPLC analysis.
As a result, the inventors have found that solid cultivation
enables the content of the sugar embedding the objective
dehydrogenase to be reduced, and thereby the amino acid sequence
thereof is revealed to obtain the gene thereof.
[0039] In order to solve the above-mentioned problems, the present
invention provides a polynucleotide encoding a soluble
coenzyme-linked glucose dehydrogenase (GLD) (hereinafter, may be
referred to as "GLD polynucleotide"), characterized by catalyzing
dehydrogenation of glucose in the presence of an electron acceptor
and exhibiting 5% or less, preferably 3% or less, and more
preferably 2% or less, of an activity toward maltose, with respect
to an activity toward glucose.
[0040] In more detail, the polynucleotide is as follows.
(A) A GLD polynucleotide is characterized in that the GLD has the
following properties 1) to 4) of: 1) utilizing flavin adenine
dinucleotide (FAD) as a coenzyme; 2) having a subunit structure of
a homodimer; 3) not utilizing oxygen as an electron acceptor; and
4) having an activity toward maltose of 5% or less, preferably 3%
or less, and more preferably 2% or less, with respect to an
activity toward glucose. (B) Alternatively, a GLD polynucleotide is
characterized in that the GLD has the following properties 1) to 3)
of: 1) utilizing flavin adenine dinucleotide (FAD) as a coenzyme;
2) not utilizing oxygen as an electron acceptor; and 3) having an
activity toward maltose of 5% or less, preferably 3% or less, and
more preferably 2% or less, with respect to an activity toward
glucose. (C) Alternatively, a GLD polynucleotide is characterized
in that the GLD has the following properties 1) to 4) of: 1)
utilizing flavin adenine dinucleotide (FAD) as a coenzyme; 2) not
utilizing oxygen as an electron acceptor; 3) having an activity
toward maltose of 5% or less, preferably 3% or less, and more
preferably 2% or less, with respect to an activity toward glucose;
and 4) having a total sugar content (galactose, glucose, mannose,
and arabinose) of 80 .mu.g or less per .mu.g of a protein. (D)
Alternatively, a GLD polynucleotide is characterized in that the
GLD has the following properties 1) to 4) of: 1) utilizing flavin
adenine dinucleotide (FAD) as a coenzyme; 2) not utilizing oxygen
as an electron acceptor; 3) having an activity toward maltose of 5%
or less, preferably 3% or less, and more preferably 2% or less,
with respect to an activity toward glucose; and 4) having a total
sugar content (galactose, glucose, mannose, arabinose) of 40 .mu.g
or less per unit of an enzyme activity; (E) Alternatively, a
polynucleotide encoding a coenzyme-linked glucose dehydrogenase
includes at least one partial nucleotide sequence selected from
consensus sequences of a nucleotide sequence encoding the
coenzyme-linked glucose dehydrogenase, set forth in SEQ ID NOs. 5
to 7, the coenzyme-linked glucose dehydrogenase having the
following properties a to d of: a having a subunit molecular weight
of approximately 63 kDa; b utilizing FAD as a coenzyme; c
catalyzing a reaction in which a hydroxyl group at the 1-position
of a glucose is oxidized and the glucose is converted to a
glucono-.delta.-lactone; and d having an activity toward maltose of
5% or less, with respect to an activity toward glucose.
[0041] In the above, the term "subunit molecular weight" set forth
in the property a refers to a subunit molecular weight determined
by subjecting a coenzyme-linked glucose dehydrogenase originating
from prokaryotic cells in which the GLD polynucleotide with or
without its signal peptide region is subjected to polyacrylamide
gel electrophoresis (SDS-PAGE), the subunit molecular weight being
within the range of 58 kDa to 63 kDa. When the subunit molecular
weight is determined using a coenzyme-linked glucose dehydrogenase
originating from eukaryotic cells, the subunit molecular weight is
within the range of 58 kDa to 150 kDa.
(F) Alternatively, a polynucleotide encoding a coenzyme-linked
glucose dehydrogenase includes at least one partial amino acid
sequence selected from consensus sequences of the coenzyme-linked
glucose dehydrogenase set forth in SEQ ID NOs. 8 to 12, the
coenzyme-linked glucose dehydrogenase having the following
properties a to d of: a having a subunit molecular weight of
approximately 63 kDa; b utilizing a FAD as a coenzyme; c catalyzing
a reaction in which a hydroxyl group at the 1-position of a glucose
is oxidized and the glucose is converted to a glucono-8-lactone;
and d having an activity toward maltose of 5% or less with respect
to an activity toward glucose.
[0042] In the above, the term "subunit molecular weight" set forth
in the property a refers to a subunit molecular weight determined
by subjecting a coenzyme-linked glucose dehydrogenase originating
from prokaryotic cells in which the GLD polynucleotide with or
without its signal peptide region is subjected to polyacrylamide
gel electrophoresis (SDS-PAGE), the subunit molecular weight being
within the range of 58 kDa to 63 kDa. When the subunit molecular
weight is determined using a coenzyme-linked glucose dehydrogenase
originating from eukaryotic cells, the subunit molecular weight is
within the range of 58 kDa to 150 kDa.
[0043] The GLD encoded by the GLD polynucleotide is an enzyme that
has physicochemical properties of catalyzing a reaction in which a
hydroxyl group at the 1-position of glucose is oxidized in the
presence of an electron acceptor with a flavin compound (flavin
adenine dinucleotide) as a coenzyme. The GLD exhibits an activity
toward maltose of 5% or less, preferably 3% or less, and more
preferably 2% or less. The activity toward maltose is inhibited by
50% or more in the presence of 1,10-phenanthroline at a final
concentration of 5 mM, preferably 2 mM, and more preferably 1 mM.
Although the subunit structure of the GLD is a homodimer, there is
a case in which a monomer thereof exhibits activity.
[0044] The total content of sugar (galactose, glucose, mannose, and
arabinose) contained in the GLD encoded by the GLD polynucleotide
is different from that of a wild type GLD, and is 80 .mu.g or less,
preferably 10 .mu.g or less, more preferably 2 .mu.g or less, and
even more preferably 0.5 .mu.g or less, per .mu.g of protein.
[0045] Also, the total content of sugar (galactose, glucose,
mannose, and arabinose) contained in the GLD encoded by the GLD
polynucleotide is different from that of a wild type GLD, and is 40
.mu.g or less, preferably 10 .mu.g or less, more preferably 2 .mu.g
or less, and even more preferably 0.5 .mu.g or less, per unit of
enzyme activity.
[0046] The GLD encoded by the GLD polynucleotide has a subunit
molecular weight of approximately 63 kDa, utilizes flavin adenine
dinucleotide (FAD) as a coenzyme, catalyzes a reaction in which a
hydroxyl group at the 1-position of glucose is oxidized and the
glucose is converted to glucono-8-lactone, and has an activity
toward maltose of 5% or less with respect to activity toward
glucose.
[0047] The GLD polynucleotide is specifically a polynucleotide
isolated from a filamentous fungi or a basidiomycete, such as, for
example, a microorganism belonging to the genus Aspergillus
Penicillium, or the genus Ganoderma, and is particularly a
polynucleotide isolated from Aspergillus terreus (A. terreus).
[0048] The specific aspect of the GLD polynucleotide according to
the present invention is a polynucleotide containing a nucleotide
sequence set forth in SEQ ID NO. 1 or a nucleotide sequence in
which at least one base is deleted from, substituted in, or added
to the nucleotide sequence set forth in SEQ ID NO. 1, and encoding
the GLD having a glucose dehydration activity realized when a
coenzyme, particularly FAD, is bonded thereto.
[0049] Also, the present invention provides a polynucleotide
containing a nucleotide sequence with a homology of at least 60% to
a polynucleotide composed of the nucleotide sequence set forth in
SEQ ID NO. 1, and encoding the GLD having a glucose dehydration
activity realized when a coenzyme, particularly FAD, is bonded
thereto.
[0050] The term "nucleotide sequence with a homology of at least
60% to a polynucleotide composed of the nucleotide sequence set
forth in SEQ ID NO. 1" refers to a nucleotide sequence of which the
identity to the full-length nucleotide sequence set forth in SEQ ID
NO. 1 is at least 60%, preferably at least 70%, more preferably at
least 80%, even more preferably at least 90%, and particularly
preferably at least 95%. The percentage of such a nucleotide
sequence identity may be calculated using a published or
commercially available software with an algorithm which conducts
comparison using a base sequence (SEQ ID NO. 1 in the present
invention) as a reference sequence. For example, BLAST, FASTA, or
GENETYX (manufactured by Software Development Co., Ltd.) may be
used, and these may be run with default parameters.
[0051] Also, the present invention provides a polynucleotide
containing a nucleotide sequence which hybridizes under stringent
conditions to a polynucleotide composed of a nucleotide sequence
complementary to a polynucleotide composed of the nucleotide
sequence set forth in SEQ ID NO. 1, and encoding the GLD having a
glucose dehydration activity exhibited by binding a coenzyme,
particularly FAD.
[0052] The first amino acid Met to the 19th amino acid Leu of the
GLD encoded by the nucleotide sequence form a signal peptide
thereof. A polynucleotide encoding this region may be suitably
substituted or deleted depending on organisms or host vector
systems.
[0053] Also, the present invention provides a method for producing
the polynucleotide encoding the GLD, in which a microorganism
having a GLD productivity is cultivated in a solid state, and the
polynucleotide is cloned based on an information of the
dehydrogenase produced. It is preferable that the microorganism
used be at least one strain belonging to the genus Aspergillus,
particularly Aspergillus terreus (A. terreus).
[0054] Moreover, the present invention provides the GLD encoded by
any one of the above-mentioned polynucleotide nucleotide sequences.
A more specific aspect of the GLD according to the present
invention is a soluble GLD which catalyzes dehydrogenation of
glucose in the presence of an electron acceptor, and has an
activity toward maltose of 5% or less with respect to an activity
toward glucose.
[0055] Also, the GLD has the following properties 1) to 4) of:
1) utilizing flavin adenine dinucleotide as a coenzyme; 2) having a
subunit structure of a homodimer; 3) not utilizing oxygen as an
electron acceptor; and 4) having an activity toward maltose of 5%
or less, preferably 3% or less, and more preferably 2% or less,
with respect to an activity toward glucose.
[0056] Alternatively, the GLD has the following properties 1) to 3)
of:
1) utilizing flavin adenine dinucleotide as a coenzyme; 2) not
utilizing oxygen as an electron acceptor; and 3) having an activity
toward maltose of 5% or less, preferably 3% or less, and more
preferably 2% or less, with respect to an activity toward
glucose.
[0057] Alternatively, the GLD has the following properties 1) to 4)
of:
1) utilizing flavin adenine dinucleotide (FAD) as a coenzyme; 2)
not utilizing oxygen as an electron acceptor; 3) having an activity
toward maltose of 5% or less with respect to an activity toward
glucose; and 4) having a total content of galactose, glucose,
mannose, and arabinose, contained therein, of 80 .mu.g or less per
.mu.g of a protein.
[0058] Alternatively, the GLD has the following properties 1) to 4)
of:
1) utilizing flavin adenine dinucleotide (FAD) as a coenzyme; 2)
not utilizing oxygen as an electron acceptor; 3) having an activity
toward maltose of 5% or less with respect to an activity toward
glucose; and 4) having a total content of galactose, glucose,
mannose, and arabinose, contained therein, of 40 .mu.g or less per
unit of an enzyme activity.
[0059] Alternatively, the GLD has the following properties of:
a. having a subunit molecular weight of approximately 63 kDa; b
utilizing a FAD as a coenzyme; c catalyzing a reaction in which a
hydroxyl group at the 1-position of a glucose is oxidized and the
glucose is converted to a glucono-8-lactone; and d having an
activity toward maltose of 5% or less with respect to an activity
toward glucose.
[0060] The GLD is isolated from filamentous fungi, preferably at
least one strain belonging to the genus Aspergillus, and more
preferably Aspergillus terreus.
[0061] A more specific aspect of the GLD according to the present
invention is a GLD containing an amino acid sequence set forth in
SEQ ID NO. 2, and which dehydrates glucose by binding to a
coenzyme, particularly FAD. Also, a GLD containing an amino acid
sequence in which at least one amino acid is deleted from,
substituted in, or added to, the amino acid sequence set forth in
SEQ ID NO. 2, and has a glucose dehydration activity exhibited by
binding FAD is provided.
[0062] Also, the present invention provides a GLD containing an
amino acid sequence with a sequence homology of at least 60% to the
amino acid sequence set forth in SEQ ID NO. 2, and has a glucose
dehydration activity exhibited by binding a coenzyme, particularly
FAD. Although coenzyme-linked glucose dehydrogenases originating
from drosophila have been conventionally known (Proc. Natl. Acad.
Sci. 1983 October; 80: 6286-6288, "Biphasic expression and function
of glucose dehydrogenase in Drosophila melanogaster."), the
homology thereof to the amino acid sequence set forth in SEQ ID NO.
2 is 45 to 47%. Moreover, it is difficult for such a dehydrogenase
originating from insects to be expressed in cells other than insect
cells, and therefore the productivity thereof is very low.
Accordingly, it is difficult for it to be industrially utilized.
The dehydrogenase according to the present invention, containing an
amino acid sequence with a sequence homology of at least 60% to the
amino acid sequence set forth in SEQ ID NO. 2, can be expressed in
an Escherichia coli bacterium or the like, and therefore, is easily
utilized as an enzyme for industrial application.
[0063] Also, the present invention provides a polynucleotide
encoding the GLD containing the amino acid sequence set forth in
SEQ ID NO. 2.
[0064] The term "amino acid sequence with a sequence homology of at
least 60% to the amino acid sequence set forth in SEQ ID NO. 2"
refers to an amino acid sequence of which the identity to the
full-length amino acid sequence set forth in SEQ ID NO. 2 is at
least 60%, preferably at least 70%, more preferably at least 80%,
even more preferably at least 90%, and particularly preferably at
least 95%. The percentage of such an amino acid sequence identity
may be calculated using a published or commercially available
software with an algorithm which conducts comparison using a base
sequence (SEQ ID NO. 2 in the present invention) as a reference
sequence. For example, BLAST, FASTA, or GENETYX (manufactured by
Software Development Co., Ltd.) may be used, and these may be run
with default parameters.
[0065] Also, the present invention provides a method for producing
the GLD, characterized in that a microorganism that produces any
one of the above-mentioned GLDs is cultivated in a solid culture
medium containing a wheat bran or an oatmeal to make the GLD
produced in the cultivated product, and then the GLD is collected,
and provides the GLD produced by the method.
[0066] Moreover, the present invention provides a recombinant
vector carrying any one of the above-mentioned polynucleotides
according to the present invention, a transformed cell prepared
using the recombinant vector, a method for producing the GLD
characterized in that the transformed cell is cultivated followed
by collecting the GLD having a glucose dehydration activity from
the cultivated product, and the GLD produced by the method.
[0067] To the GLD produced by such a method, no sugar chain is
bonded. Even if the sugar chain is bonded to the GLD, it is
generally an N-type or O-type sugar chain, and the bonding amount
thereof is smaller than that of a wild type GLD. Also, the sugar
chain is easily removed, and the GLD exhibits a high activity.
[0068] Also, the present invention provides a GLD containing an
amino acid sequence set forth in amino acid 20 to amino acid 592 of
SEQ ID NO. 2 or an amino acid sequence with a homology of at least
60% to the amino acid sequence, having a function equivalent to
that of the above-mentioned GLD, and being produced by a peptide
synthesis method or a gene recombinant method.
[0069] Moreover, the present invention provides a method for
measuring glucose characterized by utilizing the above-mentioned
GLD according to the present invention, a reagent composition for
measuring glucose characterized by containing the above-mentioned
GLD, and a biosensor for measuring glucose characterized by
utilizing the above-mentioned GLD. In a preferable aspect of these,
an electron acceptor, particularly ferricyanide, is utilized at a
final concentration of within the range of 2 mM to 500 mM.
[0070] The term "polynucleotide" refers to a molecule in which at
least 100 phosphoric esters of nucleosides in which purine or
pyrimidine is connected to sugar with a .beta.-N-glycosidic
linkage, such as, ATP (adenosine triphosphate), GTP (guanosine
triphosphate), CTP (cytidine triphosphate), UTP (uridine
triphosphate); or dATP (deoxyadenosine triphosphate), dGTP
(deoxyguanosine triphosphate), dCTP (deoxycytidine triphosphate),
and dTTP (deoxythymidine triphosphate) are bonded. In more detail,
the term "polynucleotide" includes genomic DNAs encoding the GLD,
mRNAs trancripted from the genomic DNAs, cDNAs synthesized from the
mRNAs, and polynucleotides obtained by PCR amplification using the
mRNAs as templates. The term "oligonucleotide" refers to a molecule
in which 2 to 99 nucleotides are linked together. The term
"polypeptide" refers to a molecule composed of at least 30 amino
acid residues binding together with an amide linkage (peptide
linkage) or with a linkage of unnatural residues, and further
includes ones to which sugar chains are added, and ones in which
chemical modification is artificially conducted.
[0071] Other terms in this specification or concepts of the present
invention will be circumstantially explained in the section of BEST
MODE FOR CARRYING OUT THE INVENTION and EXAMPLES. Also, various
techniques used for carrying out this invention are easily and
reliably performed by those skilled in the art based on known
documents or the like excepting techniques of which citations are
indicated. For example, genetic engineering and molecular
biological techniques can be performed in accordance with methods
disclosed in Sambrook and Maniatis, in Molecular Cloning--A
Laboratory Manual, Cold Spring Harbor Laboratory Press, New York,
1989; Ausubel, F. M. et al., Current Protocols in Molecular
Biology, John Wiley & Sons, New York, N.Y, 1995, or the like,
methods disclosed in documents cited therein, substantially
equivalent methods, modified methods, or the like. The terms used
in this specification are mainly based on IUPAC-IUB Commission on
Biochemical Nomenclature or conventionally used in the art.
Effects of the Invention
[0072] The enzyme according to the present invention is a
coenzyme-linked glucose dehydrogenase (GLD) of which the sugar
content is reduced to the level that enables the GLD to be applied
to a glucose sensor, the sugar content contained in a natural
enzyme being a great amount, the GLD having excellent properties in
terms of substrate-recognizing ability against glucose and low
activity toward maltose. Also, the method for producing the
dehydrogenase according to the present invention can produce the
dehydrogenase uniformly on a massive scale.
[0073] The sugar content of the GLD artificially produced in such a
way, the sugar content being an issue of coenzyme-linked glucose
dehydrogenases that dehydrate glucose by binding FAD, can be
controlled in accordance with objects. Accordingly, it is possible
to modify the activity toward sugar (such as glucose) contained in
samples to measure the blood sugar by preparing a dehydrogenase of
which the sugar content is decreased.
[0074] The GLD according to the present invention does not
substantially affect maltose at the time of measuring of the blood
sugar, and therefore, the GLD can be applied to a high-precision
SMBG apparatus, and greatly contributes to self-care-medication of
diabetes patients.
BRIEF DESCRIPTION OF DRAWINGS
[0075] FIG. 1 shows results of sugar chain staining performed after
cutting sugar chains of dehydrogenases and then subjecting them to
SDS-PAGE.
[0076] FIG. 2 shows results of CBB staining performed after cutting
sugar chains of dehydrogenases and then subjecting them to
SDS-PAGE.
[0077] FIG. 3 shows results of activity staining performed after
cutting sugar chains of dehydrogenases and then subjecting them to
native-PAGE.
[0078] FIG. 4 shows results of measurement of sensor
characteristics (bimolecular reaction rate constants) of
dehydrogenases using an osmium complex as an electron acceptor.
[0079] FIG. 5 shows results of measurement of sensor
characteristics (bimolecular reaction rate constants) of
dehydrogenases using a quinone compound as an electron
acceptor.
[0080] FIG. 6 shows results of quantitative analysis performed on
D-glucose using enzyme-immobilized electrodes.
BEST MODE FOR CARRYING OUT THE INVENTION
[0081] The GLD polynucleotide (gene) according to the present
invention is a polynucleotide encoding a soluble GLD characterized
by catalyzing oxidation of glucose in the presence of an electron
acceptor, and having an activity toward maltose of 5% or less,
preferably 3% or less, and more preferably 2% or less, with respect
to an activity toward glucose. In more detail, the polynucleotide
is the GLD polynucleotide characterized by having any one of the
above-mentioned properties (A) to (F).
[0082] The most specific embodiment of the GLD polynucleotide
according to the present invention is a polynucleotide containing a
nucleotide sequence set forth in SEQ ID NO. 1. The polynucleotide
is a GLD polynucleotide originating from a filamentous fungi, such
as, for example, the genus Aspergillus, particularly Aspergillus
terreus (FERM BP-08578), and encodes the GLD containing an amino
acid sequence set forth in SEQ ID NO. 2.
[0083] The GLD polynucleotide may be obtained by preparing a cDNA
library from Aspergillus terreus (FERM BP-08578), for example, and
then determining the N-terminal or internal amino acid sequence of
the GLD by Edman's method, followed by screening the cDNA library
using plural oligonucleotide probes prepared based on the amino
acid sequence.
[0084] A GLD collected from cultivated products obtained by
cultivating at least one microorganism that can yield the GLD
according to the present invention, such as, for example, at least
one strain selected from the group consisting of Aspergillus
terreus, Aspergillus japonicus (A. japonicus), and Aspergillus
oryzae (A. oryzae), which belong to the genus Aspergillus, in a
solid culture medium containing a wheat bran, oatmeal, or the like,
has a low amount of sugar chains binding to the GLD, and therefore,
can be easily purified by removing the sugar chains. Accordingly,
it is preferable that the GLD obtained by solid cultivation be used
to determine the N-terminal or internal sequence of the GLD.
[0085] When a wheat bran is used, a solution containing 40 to 70%
by mass of the wheat bran is sterilized, 0.5 to 2% by mass of a
seed culture liquid is added thereto, and cultivated at room
temperature, followed by extracting a GLD crude enzyme from the
obtained cultivated fungus body, for example. When an oatmeal is
used, a solution containing 40 to 70% by mass of the oatmeal is
sterilized, 0.5 to 2% by mass of a seed culture liquid is added
thereto, and cultivated at room temperature, followed by extracting
a GLD crude enzyme from the obtained cultivated fungus body, for
example.
[0086] Although the probe may be labeled by a radioisotope (RI)
method or non-radioisotope method, the probe is preferably labeled
by the non-radioisotope method. As the non-radioisotope method, a
fluorescent labeling method, biotin labeling method,
chemiluminescence method, or the like may be adopted, and the
fluorescent labeling method is preferably used. As the fluorescent
substance, a substance which can bind to a base portion of an
oligonucleotide may be suitably selected, and examples thereof
include cyanine pigments (such as, for example, Cy3 and Cy5 of Cy
Dye series), rhodamine 6G reagents,
N-acetoxy-N2-acetylaminofluorene (AAF), AAIFs (iodide derivatives
of AAF), and the like.
[0087] Alternatively, the objective GLD gene may be obtained by a
PCR method in which the cDNA library derived from Aspergillus
terreus (FERM BP-08578) is used as a template and a set of the
oligonucleotide primer (probe) prepared in the above is used, or by
a RT-PCR method in which a whole RNA or mRNA extracted from
Aspergillus terreus (FERM BP-08578) is used as a template. The
upstream region of the cDNA may be amplified by a 5'RACE-PCR method
using a primer with an oligonucleotide sequence set forth in the 5'
side of SEQ ID NO. 1, and the downstream region of the cDNA may be
amplified by a 3'RACE-PCR method using a primer with an
oligonucleotide sequence set forth in the 3' side of SEQ ID NO. 1.
The primer is preferably designed to have a length (base number) of
15 to 40 bases, more preferably 15 to 30 bases, in order to
satisfactorily realize specific annealing thereof to the template
DNA. In the case where the primers are used for conducting a LA
(long and accurate) PCR, the primers with a length of at least 30
bases are effectively used. A set or a pair (two) of a sense chain
(5' terminal side) and an antisense chain (3' terminal side) is
constructed so that both primers do not contain complementary
sequences thereto for preventing both primers from annealing
together. Moreover, GC content of the primers is set to be
approximately 50% so as to prevent uneven distribution of GC-rich
portions or AT-rich portions in the primers to realize stable
binding. Since the annealing temperature depends on Tm (melting
temperature), the primers whose Tm values are approximate to each
other within the range of 55 to 65.degree. C. are selected so as to
obtain a PCR product with a high specificity. Also, it is to be
noted that the final concentration of the primers used in PCR be
within the range of approximately 0.1 to approximately 1 .mu.M. A
commercially available software for designing primers, such as, for
example, Oligo.TM. (manufactured by National Bioscience Inc. (US)),
or GENETYX (manufactured by Software Development Co., Ltd.) may be
used.
[0088] The above-mentioned set of the oligonucleotide probe or
oligonucleotide primer may be prepared by cutting the
above-mentioned GLD cDNA using a suitable restriction enzyme, or by
synthesizing in vitro by a well-known chemosynthesis technique as
disclosed in documents (such as, for example, Carruthers (1982)
Cold Spring Harbor Symp. Quant. Biol. 47: 411-418; Adams (1983) J.
Am. Chem. Soc. 105: 661; Belousov (1997) Nucleic Acid Res. 25:
3440-3444; Frenkel (1995) Free Radic. Biol. Med. 19: 373-380;
Blommers (1994) Biochemistry 33: 7886-7896; Narang (1979) Meth.
Enzymol. 68: 90; Brown (1979) Meth. Enzymol. 68: 109; Beaucage
(1981) Tetra. Lett. 22: 1859; U.S. Pat. No. 4,458,066).
[0089] The polynucleotide according to the present invention is
composed of a nucleotide sequence with a homology of at least 60%
to that set forth in SEQ ID NO. 1, and may encode the GLD that
exhibits a glucose dehydration activity by binding to the coenzyme,
particularly FAD.
[0090] The polynucleotide according to the present invention may
have at least one base deleted from, substituted in, or added to
the nucleotide sequence set forth in SEQ ID NO. 1, and may encode
the GLD that realizes a glucose dehydration activity by binding to
the coenzyme, particularly FAD.
[0091] The polynucleotide according to the present invention may
have a capability of hybridization to DNA complementary to the
nucleotide sequence set forth in SEQ ID NO. 1, or DNA with a
nucleotide sequence complementary to that set forth in SEQ ID NO.
1, under stringent conditions, and also may encode the GLD that
exhibits a glucose dehydration activity by binding to the coenzyme,
particularly FAD.
[0092] The polynucleotide according to the present invention may
have at least one partial nucleotide sequence selected from
consensus sequences in the nucleotide sequence encoding the
coenzyme-linked glucose dehydrogenase, set forth in SEQ ID NOs. 5
to 7. The polynucleotide according to the present invention may
encode an enzyme having at least one partial amino acid sequence
selected from consensus sequences in the coenzyme-linked glucose
dehydrogenase, set forth in SEQ ID NOs. 8 to 12. The enzyme having
such a consensus sequence (amino acid sequence) often exhibits an
activity of the GLD according to the present invention, and
therefore, such a portion is assumed to form an active center of
the enzyme according to the present invention.
[0093] Regarding three characters "Xaa" in SEQ ID NO. 8, the first
character "Xaa" represents amino acid "Ala" or "Gly", the second
character "Xaa" represents amino acid "Ala" or "Val", and the third
character "Xaa" represents "He" or "Val". Regarding four characters
"Xaa" in SEQ ID NO. 9, the first character "Xaa" represents amino
acid "Ala" or "Val", the second character "Xaa" represents amino
acid "Ile" or "Leu", the third character "Xaa" represents amino
acid "Ala" or "Ser", and the fourth character "Xaa" represents
amino acid "Glu" or "Gln". Regarding three characters "Xaa" in SEQ
ID NO. 10, the first character "Xaa" represents amino acid "Ala" or
"Leu", the second character "Xaa" represents amino acid "Ile" or
"Leu", and the third character "Xaa" represents amino acid "Ile" or
"Val". Regarding three characters "Xaa" in SEQ ID NO. 12, the first
character "Xaa" represents amino acid "Ala" or "Ser", the second
character "Xaa" represents amino acid "Asn" or "Ser", and the third
character "Xaa" represents amino acid "Ile" or "Val".
[0094] The polynucleotides encoding such an enzyme similar to GLD
(GLD-like enzyme) may be prepared by modifying the above-mentioned
GLD cDNA derived from Aspergillus terreus in accordance with a
known mutation-introduction method, mutation-introduction PCR
method, or the like. Alternatively, the polynucleotide may be
obtained by a probe hybridization method using an oligonucleotide
prepared based on an information of the nucleotide sequence set
forth in SEQ ID NO. 1 from genomic DNAs of microorganisms other
than Aspergillus terreus or cDNA libraries thereof. The
polynucleotides encoding the GLD-like enzyme can be obtained by
varying stringent conditions for hybridization. The stringent
conditions are defined by salt concentration at a hybridization
step and washing step, concentration of an organic solvent
(formaldehyde or the like), temperature conditions, or the like,
and various conditions known by a person skilled in the art, such
as, for example, those disclosed in U.S. Pat. No. 6,100,037 or the
like, may be adopted.
[0095] In more specific hybridization conditions, a filter is
incubated at 42.degree. C. with a mixture composed of 50%
formamide, 5.times.SSC (150 mM sodium chloride, 15 mM trisodium
citrate, 10 mM sodium phosphate, 1 mM ethylenediamine tetraacetic
acid, pH 7.2), 5.times.Denhardt's solution, 0.1% SDS, 10% dextran
sulfate, and 100 .mu.g/mL of a modified salmon sperm DNA, and then
washed at 42.degree. C. with 0.2.times.SSC, for example.
[0096] The species or the genus of a microorganism used to obtain
the polynucleotide encoding the GLD-like enzyme is not limited, and
the microorganism may be a wild strain or a mutant strain. Examples
thereof include a microorganism disclosed in Patent Document 1.
[0097] The recombinant vector according to the present invention is
a cloning vector or an expression vector, and is suitably used in
accordance with the kind of an insert polynucleotide and the
application purpose thereof. For example, when the GLD or the
GLD-like enzyme is produced using the cDNA or ORF region thereof as
an insert, expression vectors for in vitro transcription, or
expression vectors suitable to prokaryotic cells, such as, for
example, Escherichia coli bacterium, or Bacillus subtilis, yeasts,
filamentous fungi, such as, for example, molds, eukaryotic cells,
such as, for example, insect cells, or mammalian cells, may be
used.
[0098] When the GLD or the GLD-like enzyme is produced on a massive
scale, the transformed cell according to the present invention may
be prepared using a prokaryotic cell such as Escherichia coli
bacterium, Bacillus subtilis, or the like, yeast, mold, eukaryotic
cell, such as insect cells, mammalian cells, or the like, for
example. The transformed cell may be prepared by introducing the
recombinant vector into cells by a known method such as an
electroporation method, calcium phosphate method, liposome method,
DEAE dextran method, or the like. Specific examples of the
recombinant vector include a recombinant vector pCGLD shown in the
following example, and specific examples of the transformed cell
include an Escherichia coli JM109/pCGLD (FERM ABP-10243) prepared
by transformation using the vector.
[0099] The GLD according to the present invention is a polypeptide
having an amino acid sequence encoded by the above-mentioned GLD
polynucleotide sequence. In more detail, it is preferable that the
GLD be a soluble coenzyme-linked glucose dehydrogenase which
catalyzes dehydrogenation of glucose in the presence of an electron
acceptor, has an activity toward maltose of 5% or less with respect
to an activity toward glucose, and further has any one of the
above-mentioned properties (A) to (F).
[0100] In a more specific aspect of the GLD according to the
present invention, the total content of sugars (galactose, glucose,
mannose, and arabinose) contained therein is 80 .mu.g or less per
.mu.g of a protein, or 40 .mu.g or less per unit of an enzyme
activity. The sugars form polysaccharides by polycondensation and
envelope the enzyme. Accordingly, when the total content of the
sugars contained therein is 80 .mu.g or less per .mu.g of a
protein, or 40 .mu.g or less per unit of an enzyme activity, the
enzyme with a high activity can be obtained, and thus such a total
content is preferable.
[0101] The more specific aspect of the GLD according to the present
invention is composed of an amino acid sequence set forth in SEQ ID
NO. 2. The GLD according to the present invention may also be a
GLD-like enzyme composed of an amino acid sequence with a homology
of at least 60% to that set forth in SEQ ID NO. 2, the GLD-like
enzyme exhibiting a glucose dehydration activity by binding to a
coenzyme, particularly FAD. The GLD according to the present
invention may be a GLD-like enzyme composed of an amino acid
sequence with at least one amino acid residue deleted from,
substituted in, or added to the amino acid sequence set forth in
SEQ ID NO. 2, the GLD-like enzyme exhibiting a glucose dehydration
activity by binding to a coenzyme, particularly FAD. The GLD
according to the present invention may be a polypeptide that has
either an amino acid sequence set forth in amino acid 20 to amino
acid 592 of SEQ ID NO. 2 or an amino acid sequence with a homology
of at least 60% to the amino acid sequence, exhibits a function
equivalent to that of the above-mentioned polypeptide, and is
synthesized by a peptide synthesis method or gene recombinant
method.
[0102] Such a GLD may be prepared, for example, based on the amino
acid sequence set forth in SEQ ID NO. 2 or a similar sequence
thereto by a known peptide synthesis method (Merrifield, R. B. J.
Solid phase peptide synthesis I. The synthesis of tetrapeptide. J.
Amer. Chem. Soc. 85, 2149-2154, 1963; Fmoc Solid Phase Peptide
Synthesis. A Practical Approach. Chan, W. C. and White, P. D.,
Oxford University Press, 2000). The peptide may be formed by a
residue linkage other than natural amide linkages. The residue
linkage other than natural amide linkages may be formed by a
chemical binding or coupling using glutaraldehyde,
N-hydroxysuccinimide ester, bifunctional maleimide,
N,N'-dicyclohexylcarbodiimide (DCC), N,N'-diisopropylcarbodiimide
(DIC), or the like. Examples of a linkage group which can be
substituted for a peptide binding include ketomethylene (for
example, --C(.dbd.O)--CH.sub.2-- instead of --C(.dbd.O)--NH--),
aminomethylene (CH.sub.2--NH), ethylene, olefin (CH.dbd.CH), ether
(CH.sub.2--O), thioether (CH.sub.2--S), tetrazole (CN.sub.4--),
thiazole, retroamide, thioamide, and ester (see, for example,
Spatola (1983) in Chemistry and Biochemistry of Amino Acids,
Peptides and Proteins, Vol. 7, pp 267-357, "Peptide Backbone
Modifications" Marcell Dekker, NY).
[0103] The GLD may be obtained by a recombinant DNA technique using
the above-mentioned GLD polynucleotide (cDNA or the coding region
thereof). For example, RNA is prepared by in vitro transcription
using a vector containing the above-mentioned polynucleotide,
followed by subjecting the RNA as a template to in vitro
translation to produce the GLD in vitro. When the polynucleotide is
inserted into a suitable expression vector by a known-method, the
GLD encoded by the polynucleotide can be yielded on a massive scale
using prokaryotic cells such as Escherichia coli bacterium,
Bacillus subtilis, or the like, yeasts, molds, eukaryotic cells
such as insect cells, mammalian cells, or the like. A host to be
used is suitably selected in accordance with necessity or not of
sugar chains, and necessity of other peptide modification.
[0104] In order to produce the GLD in vitro, a recombinant vector
is prepared by inserting the above-mentioned polynucleotide into a
vector containing a promoter to which RNA polymerase can be bonded,
followed by adding the vector to an in vitro translation system
such as rabbit blood reticulocyte lysate or wheat germ extract,
which contain RNA polymerase responding to the promoter. Examples
of the promoter to which RNA polymerase can be bonded include T3,
T7, SP6, and the like. Examples of the vector containing such a
promoter include pKA1, pCDM8, pT3/T718, pT7/319, pBluescript II,
and the like.
[0105] In the case where the GLD is produced by expressing DNA
thereof in a microorganism such as Escherichia coli bacterium or
the like, the GLD can be produced on a massive scale in the
microorganism by preparing a recombinant expression vector in which
the above-mentioned polynucleotide is inserted into an expression
vector replicable in the microorganism, the expression vector
having an origin, promoter, ribosome binding site, DNA cloning
site, terminator sequence, and the like, followed by transforming
host cells with the recombinant expression vector, and then
cultivating the transformed cells. In this case, a GLD fraction
containing an optional region can be obtained by adding an
initiation codon and a stop codon in front of and behind a coding
region of the optional region, followed by expressing the optional
region. Alternatively, the GLD may be expressed as a protein fused
with another protein. The fused protein may be cut with a suitable
protease to obtain an objective GLD. Examples of the expression
vector used in an Escherichia coli bacterium include pUC vectors,
pBluescript II, pET expression vectors, pGEX expression vectors,
pCold expression vectors, and the like.
[0106] The GLD can be produced in a eukaryotic cell by preparing a
recombinant vector in which the above-mentioned polynucleotide is
inserted into an expression vector replicable in eukaryotic cells,
the expression vector having a promoter, splicing region,
polyA-addition site, and the like, followed by transforming the
eukaryotic cells with the recombinant vector. The recombinant
vector may be held in the cells in such a state as that of a
plasmid or may be held by incorporating it in a chromosome.
Examples of the expression vector include pKA1, pCDM8, pSVK3, pSVL,
pBK-CMV, pBK-RSV, EBV vector, pRS, pYE82, and the like. When
pIND/V5-His, pFLAG-CMV-2, pEGFP-N1, pEGFP-C1, or the like is used
as the expression vector, FAD-GLD polypeptide can be expressed as a
fused protein to which a tag, such as His-tag, FLAG-tag, GFP or the
like, is added. Although mammalian culture cells, such as monkey
kidney cells COS-7, Chinese hamster ovary cells CHO, or the like,
budding yeasts, fission yeasts, molds, silkworm cells, xenopus
oocytes, are generally used as the eukaryotic cells, any eukaryotic
cells may be used provided that they can yield the GLD. In order to
introduce the expression vector into the eukaryotic cell, a known
method such as an electroporation method, calcium phosphate method,
liposome method, DEAE dextran method, or the like, may be
adopted.
[0107] After the GLD is yielded in prokaryotic cells or eukaryotic
cells, the objective protein is purified following isolation from
cultivated products (such as, for example, fungus body, or
cultivated liquid or culture medium composition, containing the
enzyme secreted outward of the fungus body) by combining known
separation procedures. Examples of such procedures include a
treatment using a denaturant such as urea or a surfactant, thermal
treatment, pH treatment, sonication, enzymatic digestion,
salting-out or solvent precipitation method, dialysis,
centrifugation, ultrafiltration, gel filtration, SDS-PAGE,
isoelectric focusing electrophoresis, ion-exchange chromatography,
hydrophobic chromatography, reversed-phase chromatography, affinity
chromatography (including a method in which a tag sequence is
utilized and a method in which a polyclonal or monoclonal antibody
that is specific to UKC1 is utilized).
[0108] The GLD according to the present invention, which is
prepared by the above-mentioned method, has the following
characteristics.
(1) Action: The GLD is an enzyme classified in class EC 1.1.99.10
by International Union of Biochemistry (IUB) and catalyzes reaction
in which a hydroxyl group at the 1-position of glucose is oxidized
in the presence of an electron acceptor to produce
glucono-.delta.-lactone (glucose+electron
acceptor.fwdarw.glucono-.delta.-lactone+reduced-form electron
acceptor).
[0109] Examples of the electron acceptor for use include
phenazinemethosulfate, 1-methoxy-5-methylphenazium methylsulfate,
2,6-dichlorophenolindophenol, ferricyanide compounds, osmium
compounds, quinone compounds, and the like.
(2) Substrate selectivity: The GLD strongly acts on D-glucose, but
weakly acts on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose,
D-trehalose, maltose, D-galactose, D-glucose-6-phosphate, and
D-fructose. The GLD exhibits almost no action on L-arabinose,
lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose,
D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol,
and glycerol. (3) Inhibitor: At least 60% of the activity is
inhibited by 1,10-phenanthroline. (4) Coenzyme: Flavin adenine
dinucleotide
(5) Optimum pH: 7.0 to 9.0
(6) Stable pH: 4.5 to 8.5
[0110] (7) Optimum temperature: approximately 55.degree. C. (8)
Temperature stability: The GLD is stable at approximately
50.degree. C. or lower.
[0111] Since sugar chains attach to the enzyme, the above-mentioned
molecular weight thereof varies in accordance with cultivating
conditions or purification conditions. In the case of the
recombinant, the kind of sugar chain or amino acid attaching
thereto varies in accordance with the kind of the host or vector
used, and therefore, the molecular weight thereof also varies.
[0112] It is ascertained that the isoelectric focusing also varies
in a similar manner to the above.
[0113] As described above, the GLD according to the present
invention is an enzyme which catalyzes dehydrogenation of glucose
in the presence of an electron acceptor, and therefore, the use
thereof is not particularly limited, provided that it utilizes the
change caused by the dehydrogenation. For example, the GLD may be
used in medical fields or clinical fields for measuring glucose in
samples containing biomaterials, or for composing a reagent for
measuring glucose or a reagent for eliminating glucose.
Alternatively, the GLD may be used for producing a substance using
a coenzyme-linked glucose dehydrogenase.
[0114] The biosensor according to the present invention contains
the GLD according to the present invention as an enzyme in a
reaction layer, and is a glucose sensor for measuring glucose
concentration in sample liquids. For example, the biosensor is
prepared by forming an electrode system having a working pole,
counter pole thereof, and reference pole, on an insulating base
plate by a screen printing method or the like, followed by forming
an enzyme reaction layer containing a hydrophilic polymer,
oxidoreductase, and electron acceptor, onto the electrode system.
When a sample liquid containing a substrate is dropped onto the
enzyme reaction layer of the biosensor, the enzyme reaction layer
is dissolved, and then the substrate is reacted with the enzyme, as
a result of which the electron acceptor is reduced. After the
enzyme reaction is ended, the reduced electron acceptor is
electrochemically oxidized to measure the oxidation current value.
The concentration of the substrate in the sample liquid is
determined by the oxidation current value. In addition to the
above, a biosensor that detects change of developed color or pH may
be constructed.
[0115] As the electron acceptor of the biosensor, chemical
substances that have an excellent electron donating and accepting
ability may be used. The term "chemical substances that have an
excellent electron donating and accepting ability" refer to
chemical substances generally called an "electron carrier",
"mediator" or "redox mediator", and examples thereof include
electron carriers and redox mediators disclosed in Published
Japanese translation No. 2002-526759 of PCT International
Publication. Specific examples thereof include osmium compounds,
quinone compounds, ferricyanide compounds, and the like.
[0116] As the electron acceptor of the biosensor, cheap potassium
ferricyanide (potassium hexacyanoferrate (III)) is often used at
the final concentration of 1 mM or less. However, D-glucose can be
further sensitively measured by using potassium ferricyanide in a
high concentration of 2 to 500 mM, and more preferably 30 to 100
mM. It is preferable that potassium ferricyanide be used at the
final concentration of 2 to 500 mM in the measurement reaction
system of the measurement method, reagent for measurement, compound
for measurement, or biosensor, according to the present
invention.
[0117] In measurement of the activity of the enzyme according to
the present invention, it is preferable that the enzyme be suitably
diluted to the final concentration of 0.1 to 1.0 unit/ml, for use.
One unit of the enzyme activity is equivalent to the enzyme
activity that oxidizes 1 .mu.mol of glucose per minute. The enzyme
activity of the coenzyme-linked glucose dehydrogenase according to
the present invention may be determined in accordance with the
following method.
(i) Enzyme Activity Measurement Method-1
[0118] 1.0 ml of 0.1 M potassium phosphate buffer (pH 7.0), 1.0 ml
of 1.0 M D-glucose, 0.1 ml of 3 mM 2,6-dichlorophenolindophenol
(hereinafter, referred to as DCIP), 0.2 ml of 3 mM
1-methoxy-5-methylphenazium methylsulfate, and 0.65 ml of water are
placed in a 3 ml quartz cell (with an optical path length of 1 cm),
and then the cell is placed in a spectrophotometer equipped with a
thermostat cell holder. After the cell is incubated at 37.degree.
C. for five minutes, 0.05 ml of an enzyme liquid is added thereto,
followed by measuring absorbance change (AABS/min) of DCIP at 600
nm. The mol-absorption coefficient of DCIP at pH 7.0 is defined to
be 16.3.times.10.sup.3 cm.sup.-1M.sup.-1. Since one unit of the
enzyme activity is substantially equivalent to the enzyme activity
that reduces 1 .mu.mol of DCIP per minute, the enzyme activity is
determined by absorbance change in accordance with the following
formula.
Enzyme activity ( unit / ml ) = - .DELTA. ABS 16.3 .times. 3.0 0.05
.times. dilution rate of enzyme ##EQU00001##
(ii) Enzyme Activity Measurement Method-2
[0119] After 3.4 .mu.l of 1.0 M potassium phosphate buffer (pH
7.0), 0.1 ml of 1.0 M D-glucose, and 86.6 .mu.l of 20 mM DCIP are
incubated at 37.degree. C. for five minutes, 0.01 ml of an enzyme
liquid is added thereto and then stirred to react the mixture for
five minutes, followed by incubating the mixture for three minutes
at 100.degree. C. to stop the reaction. Moreover, 0.19 ml of 100 mM
glycine/sodium buffer (pH 13.0) and 0.01 ml of 2.0 N potassium
hydroxide are further added and incubated at 37.degree. C. for ten
minutes to convert D-gluconic acid in the mixture to
D-glucono-.delta.-lactone, followed by adding 0.39 ml of 100 mM
Tris-hydrochloride buffer (pH 7.5) and 0.01 ml of 1.0N hydrochloric
acid thereto to obtain a neutral pH. The amount of D-gluconic acid
in the mixture is quantitatively analyzed using a D-gluconic
acid/D-glucono-.delta.-lactone quantitative analysis kit
(manufactured by Roche Diagnostics K.K.). Since the enzyme activity
that produces one .mu.mol of D-glucono-.delta.-lactone per minute
is substantially equivalent to one unit of the enzyme activity, the
enzyme activity is determined based on the yield amount of
D-glucono-.delta.-lactone.
[0120] In measurement of the protein concentration of the enzyme,
the enzyme is preferably used by suitably diluting it to the final
concentration of 0.2 to 0.9 mg/ml. The protein concentration may be
determined by using a kit for measuring the protein concentration,
purchased from Bio-Rad Laboratories, Inc., under the trade name of
Bio-Rad Protein Assay, in accordance with an instruction manual,
and calculating using a standard curve drawn by using bovine serum
albumin (BSA, manufactured by Wako Pure Chemical Industries, Ltd.,
biochemical reagent) as a standard substance.
[0121] In the following, the present invention will be further
circumstantially explained by showing some examples. However, the
present invention is not limited to the following examples.
Example 1
1-1 (Seed Cultivation)
[0122] A pH of a liquid culture medium composed of 1% (W/V) glucose
(manufactured by Wako Pure Chemical Industries, Ltd.), 2% (W/V)
defatted soybean (manufactured by Nihon Syokuhan Co., Ltd.), 0.5%
(W/V) corn steep liquor (manufactured by San-ei Sucrochemical Co.,
Ltd.), 0.1% (W/V) magnesium sulfate heptahydrate (manufactured by
Nacalai Tesque, Inc.) and water was adjusted to 6.0. 100 mL of the
liquid culture medium was placed in a Sakaguchi flask of 500 ml
capacity, and plugged with cotton, followed by performing autoclave
treatment at 121.degree. C. for 20 minutes. After the culture
medium was cooled, a strain of Aspergillus terreus (FERM BP-08578)
was inoculated thereto, followed by cultivating while shaking at
28.degree. C. for 48 hours to obtain a seed culture liquid.
1-2 (Obtaining Crude Enzyme Liquid by Liquid Cultivation)
[0123] A pH of 4 L of a liquid culture medium composed of 1% (W/V)
glucose (manufactured by Wako Pure Chemical Industries, Ltd.), 2%
(W/V) defatted soybean (manufactured by Nihon Syokuhan Co., Ltd.),
0.5% (W/V) corn steep liquor (manufactured by San-ei Sucrochemical
Co., Ltd.), 0.1% (W/V) magnesium sulfate heptahydrate (manufactured
by Nacalai Tesque, Inc.), an antifoamer, and water, was adjusted to
6.0. The liquid culture medium was placed in a jar fermenter of 5 L
capacity, followed by performing autoclave treatment at 121.degree.
C. for 20 minutes to sterilize the liquid culture medium. After the
liquid culture medium was cooled, 40 mL of the culture liquid
disclosed in the above paragraph 1-1 (Seed cultivation) was seeded
to the liquid culture medium, followed by cultivating fungus bodies
for 41 hours under aerating and agitating conditions. The culture
liquid was filtered to obtain a culture supernatant as a crude
enzyme liquid 1.
1-3 (Obtaining Crude Enzyme Liquid by Solid Cultivation (Bran
Cultivation))
[0124] 300 g of wheat bran (manufactured by Yowa Seifun Co., Ltd.)
and 240 g of tap water were put into a conical flask of 5 L
capacity, and then stirred well. The conical flask was plugged with
cotton, and then sterilized at 121.degree. C. for 25 minutes.
[0125] 5 mL of the seed culture liquid disclosed in the
above-paragraph 1-1 (Seed cultivation) was seeded, and then left
still at 26.degree. C. for cultivation. After cultivation was
performed for 2 weeks while occasionally stirring for aeration,
cultivated fungus bodies attaching to the bran were subjected to
extraction using 5 L of 20 mM potassium phosphate buffer (pH 7.5),
and then filtration to obtain a supernatant as a crude enzyme
liquid 2.
1-4 (Obtaining Crude Enzyme Liquid by Solid Cultivation (Oatmeal
Cultivation))
[0126] 300 g of oatmeal (manufactured by Snow Brand Milk Products
Co., Ltd.) and 240 g of tap water were put into a conical flask of
5 L capacity, and then stirred well. The conical flask was plugged
with cotton, and then sterilized at 121.degree. C. for 25
minutes.
[0127] 5 mL of the seed culture liquid disclosed in the
above-paragraph 1-1 (Seed cultivation) was seeded, and then
cultivated for four days at 25.degree. C. by leaving it still while
occasionally stirring for aeration. The cultivated fungus bodies
attaching to the oatmeal were subjected to extraction using 5 L of
20 mM potassium phosphate buffer (pH 7.5), and then filtration to
obtain a supernatant as a crude enzyme liquid 3.
1-5 (Purification of Enzyme)
[0128] The crude enzyme liquids 1 to 3 were subjected to enzyme
purification by the following steps (1) to (5) to isolate the
coenzyme-linked glucose dehydrogenase.
(1) Concentration and Desalination
[0129] Each crude enzyme liquid was concentrated using an
ultrafiltration filter "Pellicon 2 modules" (manufactured by
Millipore Corporation) with a molecular weight cutoff of 10,000,
and then substituted with 20 mM potassium phosphate buffer (pH 7.5)
to obtain each crude enzyme concentrate.
(2) Purification Using Butyl-TOYOPEARL650M (Manufactured by Tosoh
Corporation) (First Time)
[0130] The above-mentioned crude enzyme concentrate was adjusted to
be a 65% ammonium sulfate saturated solution (pH 7.5), and then
centrifuged to obtain a supernatant. The crude enzyme supernatant
was passed through a Butyl-TOYOPEARL650M column which was
previously equilibrated with 20 mM potassium phosphate buffer (pH
7.5) containing 65% saturated ammonium sulfate so that the enzyme
was adsorbed to the column. After the column was washed with the
same buffer, the enzyme was eluted using 20 mM potassium phosphate
buffer (pH 7.5) containing 30% saturated ammonium sulfate to
collect an active fraction. Moreover, the enzyme was eluted by a
gradient elution method using the same buffer to 20 mM potassium
phosphate buffer (pH 7.5), and then mixed with the above-mentioned
active fraction.
(3) Purification Using DEAE-CELLULOFINE A-500 (Manufactured by
SEIKAGAKU CORPORATION)
[0131] The above-mentioned activity fraction was concentrated using
an ultrafiltration filter "Pellicon 2 modules" with a molecular
weight cutoff of 10,000, and then desalinated, followed by
equilibrating with 15 mM Tris-hydrochloride buffer (pH 8.5). A
DEAE-CELLULOFINE A-500 column was equilibrated with the same
buffer, and the the fraction was passed through the column to
collect an active fraction.
(4) Purification Using Butyl-TOYOPEARL650M (Manufactured by Tosoh
Corporation) (Second Time)
[0132] The activity fraction was adjusted to be a 65% ammonium
sulfate saturated solution (pH 7.5), and then centrifuged to obtain
a supernatant. The supernatant was passed through a
Butyl-TOYOPEARL650M column previously equilibrated with 20 mM
potassium phosphate buffer (pH 7.5) containing 65% saturated
ammonium sulfate so that the enzyme was adsorbed to the column.
After the column was washed with the same buffer, the enzyme was
eluted with 20 mM potassium phosphate buffer (pH 7.5) containing
30% saturated ammonium sulfate to collect an active fraction.
(5) Purification Using TSK-Gel G3000SW (Manufactured by Tosoh
Corporation)
[0133] The above-mentioned active fraction was concentrated with a
pencil-type membrane concentration module "ACP-0013" with a
molecular weight cutoff of 13,000 (manufactured by Asahi Kasei
Corporation), and then desalinated, followed by equilibrating with
50 mM potassium phosphate buffer (pH 5.5) containing 0.2 M sodium
chloride. The fraction was passed through a TSK-gel G3000SW (with a
diameter of 2.15 cm and a height of 60 cm) equilibrated with the
same buffer, and then the enzyme was eluted with the same buffer to
collect an active fraction. The active fraction was concentrated
with CENTRIPLUS 10 (manufactured by Amicon Inc.), and then
desalinated, followed by being substituted with 50 mM sodium
citrate/phosphate buffer (pH 5.5). The specific activity of the
enzyme purified from the crude enzyme liquid 1 (hereinafter,
referred to as "purified enzyme 1") was approximately 1,800
units/mg. The specific activity of the enzyme purified from the
crude enzyme liquid 2 (hereinafter, referred to as "purified enzyme
2") was approximately 1,010 units/mg. The specific activity of the
enzyme purified from the crude enzyme liquid 3 (hereinafter,
referred to as "purified enzyme 3") was equivalent to the above.
The purification fold of each enzyme was 100-fold or more with
respect to the crude enzyme liquid.
Example 2
Preparation of Vector Containing Insert DNA
(1) Isolation of Whole RNA
[0134] 2 g of wet fungus bodies cultivated by the method described
in the above paragraph 1-1 (Seed culture) of Example 1 were frozen
with liquid nitrogen, and then 1.5 mg of whole RNA thereof was
extracted using EASY Prep RNA (manufactured by TAKARA BIO
INC.).
(2) Preparation of cDNA Library
[0135] A cDNA library was prepared from the whole RNA by performing
reverse transcription using a reverse transcriptase and oligo dT
adaptor primer. As a regent, "3'-Full RACE Core Set" (manufactured
by TAKARA BIO INC.) was used under conditions disclosed in the
protocol of the operating manual thereof.
(3) Cloning of GLD Gene
[0136] The GLD gene was amplified by PCR using the cDNA library as
a template. As primers, plural oligonucleotides were synthesized
based on the N-terminal and internal amino acid sequence of
purified enzyme 2 free from embedding sugar, the amino acid
sequence being determined by Edman's method, the purified enzyme 2
being obtained by purifying the crude enzyme liquid 2 in accordance
with the method described in the above-paragraph 1-5 (purification
of enzyme) of Example 1, and the crude enzyme liquid 2 being
obtained by bran cultivation as described in the paragraph 1-3
(solid cultivation (bran cultivation)) of Example 1. Finally, a
primer set of KpnF (SEQ ID NO. 3) and PstR (SEQ ID NO. 4) primers
was used to obtain an objective GLD gene.
[0137] PCR was performed using a DNA polymerase and Pyrobest
(manufactured by TAKARA BIO INC.) by performing 25 cycles of
(94.degree. C. for 30 seconds.fwdarw.55.degree. C. for one
minute.fwdarw.72.degree. C. for two minutes).
[0138] Then, a pColdIII vector (manufactured by TAKARA BIO INC.)
was cleaved with restriction enzymes PstI and KpnI, and then the
PCR-amplified fraction treated with the same restriction enzymes
was ligated to the vector, followed by being transfected to an
Escherichia coli bacterium DH5.alpha. strain for transformation.
Plasmid DNAs were prepared from 6 clones of obtained transformants,
and then treated with the restriction enzymes PstI and KpnI, as a
result of which each clone was conformed to have a fraction with an
objective size. Among them, plasmids of 4 clones were prepared to
determine the sequence of the insert contained therein, and each
plasmid was confirmed to have an objective gene.
Example 3
Transformation of Host and Purification of Enzyme
[0139] A host Escherichia coli bacterium JM109 strain was
transformed with the recombinant vector (pCGLD) prepared in Example
2, and transformant was selected on LB agar medium containing
ampicillin. Then, the transformant was seeded in LB liquid culture
medium containing 50 .mu.g/ml of ampicillin, and then cultivated
while shaking at 37.degree. C. When the OD600 of the cultivated
liquid reached approximately 0.4 to 0.5, the cultivated liquid was
cooled to 15.degree. C., and then left still for 30 minutes,
followed by adding 1 mM IPTG thereto, and then further cultivating
while shaking at 15.degree. C. for 24 hours. After the cultivation
was ended, the fungus bodies were collected by centrifugation, and
then suspended with 10 mM potassium phosphate buffer (pH 7.5).
After the fungus bodies were sonicated using a sonicator, a
cell-free extract was obtained by centrifugation. It was confirmed
by SDS-PAGE and activity measurement that an enzyme with an
anticipated molecular weight was expressed. Also, it was confirmed
that the enzyme activity was 0.09 U/mL of the cultivated
liquid.
[0140] Moreover, the coenzyme-linked glucose dehydrogenase was
isolated and purified by the following steps (1) to (5).
(1) Concentration
[0141] The above-mentioned cell-free extract was concentrated with
an ultrafiltration filter "Pellicon 2 modules" with a molecular
weight cutoff of 10,000 (manufactured by Millipore Corporation),
followed by substituting with 20 mM potassium phosphate buffer (pH
7.5) to obtain a crude enzyme liquid.
(2) Purification Using Butyl-TOYOPEARL650M (Manufactured by Tosoh
Corporation) (First Time)
[0142] The above-mentioned crude enzyme liquid was adjusted to be a
65% ammonium sulfate saturated solution (pH7.5), followed by
centrifuging to obtain a supernatant. The obtained crude enzyme
supernatant was passed through a Butyl-TOYOPEARL650M column
previously equilibrated with 20 mM potassium phosphate buffer (pH
7.5) containing 65% ammonium sulfate so that the enzyme was
adsorbed. After the column was washed with the same buffer, the
enzyme was eluted with 20 mM potassium phosphate buffer (pH 7.5)
containing 30% ammonium sulfate to collect an active fraction.
Furthermore, the enzyme was eluted by a gradient elution method
using the same buffer to 20 mM potassium phosphate buffer (pH 7.5),
and the collected active fraction was added to the above-mentioned
active fraction.
(3) Purification Using DEAE-CELLULOFINE A-500 (Manufactured by
SEIKAGAKU CORPORATION)
[0143] The above-mentioned active fraction was concentrated with an
ultrafiltration filter "Pellicon 2 modules" with a molecular weight
cutoff of 10,000, and then desalinated, followed by equilibrating
with 15 mM Tris-hydrochloride buffer (pH8.5). The fraction was
passed through a DEAE-CELLULOFINE A-500 column equilibrated with
the same buffer to collect the eluant.
(4) Purification Using Butyl-TOYOPEARL650M (Manufactured by Tosoh
Corporation) (Second Time)
[0144] The eluant was adjusted to be a 65% ammonium sulfate
saturated solution (pH 7.5), and then centrifuged to obtain a
supernatant. The supernatant was passed through a
Butyl-TOYOPEARL650M column previously equilibrated with 20 mM
potassium phosphate buffer (pH 7.5) containing 65% ammonium sulfate
so that the enzyme was adsorbed. After the column was washed with
the same buffer, the enzyme was eluted with 20 mM potassium
phosphate buffer (pH 7.5) containing 30% ammonium sulfate to
collect an active fraction.
(5) Purification Using TSK-Gel G3000SW (Manufactured by Tosoh
Corporation)
[0145] The above-mentioned active fraction was concentrated with a
pencil-type membrane concentration module "ACP-0013" (manufactured
by Asahi Kasei Corporation) with a molecular weight cutoff of
13,000, and then desalinated, followed by equilibrating with 50 mM
potassium phosphate buffer (pH 5.5) containing 0.2 M sodium
chloride. The fraction was passed through TSK-gel G3000SW (with a
diameter of 2.15 cm and a height of 60 cm) equilibrated with the
same buffer, and then the enzyme was eluted with the same buffer to
collect an active fraction. The active fraction was concentrated
with CENTRIPLUS 10 (manufactured by Amicon Inc.), and then
desalinated, followed by substituting with 50 mM sodium
citrate/phosphate buffer (pH 5.5). The obtained enzyme
(hereinafter, referred to as "purified enzyme 4") had a specific
activity of approximately 2,450 units/mg and a purification fold of
approximately 50-fold with respect to the crude enzyme liquid.
Example 4
Transformation of Mold and Purification of Enzyme
[0146] As a host, a strain of A. oryzae NS4 was used. As disclosed
in Known Document 1 (Biosci. Biotech. Biochem., 61(8), 1367-1369,
1997), this strain was bred in 1997 (Heisei 9) at the National
Research Institute of Brewing, has been used for analyzing
transcription factors, culturing various strains with a high
ability of yielding an enzyme, or the like, and has been
commercially available.
[0147] A vector which can realize expression of the GLD gene was
prepared using an improved amylase promoter derived from A. oryzae
for gene expression in the strain as disclosed in Known Document 2
(Heterologous gene expression system in the genus Aspergillus,
Toshitaka Minetoki, Chemistry & Biology, 38, 12, P831-838,
2000). Transformation was performed basically in accordance with a
method disclosed in Known Document 2 and Known Document 3 (Genetic
engineering of Aspergillus oryzae for Japanese Sake, Masaya Gomi,
Journal of the Brewing Society of Japan, pages 494 to 502, 2000).
Selection of transformant with activity was repeatedly performed to
obtain a strain of Aspergillus oryzae with an ability of yielding
the GLD.
[0148] The strain was cultivated while shaking at 30.degree. C. for
5 days in a liquid culture medium containing 1% peptone, 2%
sucrose, 0.5% dipotassium hydrogen phosphate, and 0.05% magnesium
sulfate to obtain a cultivated liquid with a GLD activity.
[0149] Purification was performed in accordance with the same
method as that of Example 3, and then SDS polyacrylamide gel
electrophoresis was performed to obtain an approximately single
enzyme sample. The sample is referred to as "purified enzyme
5".
Example 5
Transformation of Yeast and Purification of Enzyme
[0150] A host used was a strain prepared by improving a strain of
Candida boidinii S2 AOU-1, which is known as a yeast with a high
ability of yielding protein, in accordance with a method disclosed
in Known Document 4 (Laboratory Manual for Gene Expression,
Production of useful protein in high expression system, edited by
Isao Ishida and Tamie Ando, Kodansya Scientific Ltd., pages 100 to
129, 1994) for transfection of a heterologous gene. The strain of
S2 AOU-1 was named as Candida boidinii SAM1958 and deposited in the
National Institute of Bioscience and Human-Technology as Accession
No. FERM BP-3766 on Feb. 25, 1992.
[0151] A vector which realizes expression of the GLD gene in the
improved strain was prepared using a promoter induced by methanol,
the promoter being derived from the strain of S2 AOU-1 as disclosed
in Known Document 5 (Heterologous gene expression system by
methanol-utilizing yeast, Hiroya Yurimoto and Yasuyoshi Sakai,
Chemistry & Biology, 38, 8, P533-540, 2000). Then,
transformants were selected in accordance with Known Documents 4
and 5 to obtain a strain of Candida boidinii with an ability of
yielding the GLD.
[0152] The strain was cultivated while shaking at 28.degree. C. for
two days in a liquid culture medium containing 2% peptone, 1% yeast
extract, 2% glycerol, and 1% methanol to obtain a cultivated liquid
with a GLD activity.
[0153] Purification was performed in accordance with the same
method as that of Example 3, and then SDS polyacrylamide gel
electrophoresis was performed to obtain an approximately single
enzyme sample. The sample is referred to as "purified enzyme
6".
Example 6
Enzymatic Decomposition
[0154] 0.1% (v/v) SUMIZYME PX and 0.1% (v/v) SUMIZYME ARS were
added to a portion of the crude enzyme liquid 1 prepared in
paragraph 1-2 of Example 1 (obtaining crude enzyme liquid by liquid
cultivation), and then reacted at 40.degree. C. for two hours.
After the reaction was ended, the reactant was subjected to
SDS-PAGE, and then sugar chain staining using a sugar chain
staining kit (Gelcode Glycoprotein Staining Kit (manufactured by
PIERCE)) in accordance with a determined method. However, no
decomposition of sugar chains could be recognized.
(Oxidation, Reduction, and Acid Hydrolysis by Metaperiodic
Acid)
[0155] The crude enzyme liquid 1 was put into a 1.5 ml Eppendorf
tube covered with aluminum foil in a protein amount of 20 .mu.g,
and then an eighth part of 0.8N sodium metaperiodate (NaIO.sub.4)
aqueous solution (final concentration thereof was 0.1N) was added
thereto, followed by performing oxidation at 25.degree. C. for 24
hours. Then, to the solution, a tenth part of 0.4N NaBH.sub.4
aqueous solution was added, followed by performing reduction at
room temperature for 10 hours. Furthermore, to this solution, a
tenth part of 1N sulfuric acid aqueous solution was added, followed
by performing hydrolysis at 25.degree. C. for 24 hours. In the same
manner as that of the above-mentioned enzymatic decomposition test,
the reactant was subjected to SDS-PAGE and then sugar chain
staining using a sugar chain staining kit. However, no
decomposition of sugar chains could be recognized.
(Electrophoresis (Sugar Chain Staining, Coomassie Brilliant Blue
(CBB) Staining, and Activity Staining))
[0156] To each enzyme liquid (purified enzymes 1, 2, 4, 5, and 6)
prepared in Examples 1 to 5, one unit of glycopeptidase F
(manufactured by Wako Pure Chemical Industries, Ltd.) was added per
0.1 mg of a protein therein, and then reacted at 37.degree. C. for
15 hours to cut sugar chains, followed by subjecting to SDS-PAGE.
The SDS-PAGE gel was subjected to sugar chain staining to confirm
the amount of sugar chains and whether the sugar chains were cut.
The sugar chain staining was performed using a sugar chain staining
kit (Gelcode Glycoprotein Staining Kit (manufactured by PIERCE)) in
accordance with a determined method (FIG. 1). As a result,
existence of a great deal of sugar in the purified enzyme 1
prepared from the liquid cultivation supernatant was confirmed, and
no difference between before and after treatment of cutting sugar
chains was recognized, and therefore, it was assumed that the
glycopeptidase F provided no influence thereon. On the other hand,
it was confirmed that the molecular weights of the purified enzymes
2, 5, and 6, purified from the products cultivated in a solid
state, decreased by cutting the sugar chains, and a portion of the
sugar chains was cut with the glycopeptidase F.
[0157] Also, when SDS-PAGE and then Coomassie Brilliant Blue (CBB)
staining were performed in the same way, the purified enzyme 1 was
hardly stained with CBB, but the purified enzymes 2, 4, 5, and 6
were stained well with CBB (FIG. 2). As is apparent from the above
results, the purified enzymes prepared by solid cultivation or gene
recombination had a lower binding sugar content and were easily
stained with CBB in comparison with the purified enzyme prepared by
liquid cultivation.
[0158] Also, electrophoresis analysis was performed by native-PAGE
using an electrophoresis gel of NPU-7.5 L for native-PAGE
(manufactured by ATTO CORPORATION), and then an activity staining
was performed. Results thereof are shown in FIG. 3. Lane 7
indicates a result of a sample prepared by liquid cultivation, the
enzyme activity thereof being adjusted to 20 mU. Lane 8 indicates a
result of a sample prepared by bran cultivation, the enzyme
activity thereof being adjusted to 20 mU. Lane 9 indicates a result
of a sample prepared by oatmeal cultivation, the enzyme activity
thereof being adjusted to 20 mU. Lane 7 indicates a result of the
purified enzyme 1, lane 8 indicates a result of the purified enzyme
2, and lane 9 indicates a result of the purified enzyme 3.
[0159] The electrophoresis position of the purified enzymes 2 and
3, which are purified from the products cultivated in a solid
state, was lower than that of the purified enzyme 1 purified from
the supernatant cultivated in a liquid state. As is apparent from
the above results, the sugar content in the obtained enzyme was
decreased by changing the cultivation state from a liquid state to
a solid state, and thereby, the obtained enzyme was easily stained
with CBB.
[0160] In consideration of the results of the above examples, it
was assumed that the purified enzyme 1 and the other purified
enzymes differed in the sugar content and sugar composition, and so
the sugar analysis of the enzymes was performed.
Example 7
Analysis of Sugar Composition by ABME Labeling--HPLC Analysis
[0161] First, 35 mg of methyl p-aminobenzoate (ABME) and 3.5 mg of
sodium cyanoborohydride were put into a test tube, and then 350
.mu.l of methanol and 41 .mu.l of acetic acid were added, followed
by stirring the mixture.
[0162] Each purified enzyme liquid prepared in the above-mentioned
Examples 1 to 5 was adjusted to have a protein content of 1.0
mg/ml, and then 100 .mu.l thereof was put into a test tube equipped
with a screw cap, followed by drying up to harden under a nitrogen
gas stream, adding 0.2 ml of 4N TFA (trifluoroacetic acid) solution
thereto, and then reacting at 100.degree. C. for 4 hours. After the
reaction was ended, the reactant was dried up to harden under a
reduced pressure in a tube evaporator, followed by adding 200 .mu.l
of ion-exchanged water thereto. Then, the drying-up procedure was
repeated three times, and thus TFA was completely removed. In a
fume hood, 200 .mu.l of methanol, 20 .mu.l of pyridine, and 20
.mu.l of acetic acid anhydride were added to the resultant, and
then left still at room temperature for two hours or longer to
perform N-acetylation. The reactant liquid was dried up to harden
under a nitrogen gas stream, and then dissolved in 1 ml of
ion-exchanged water, followed by passing it through a cartridge
column of PRE-SEP C18 (manufactured by Waters Corporation)
previously washed, and then performing elution with 15 ml of
ion-exchanged water. The eluant was concentrated under a reduced
pressure using a rotary evaporator, and then transferred to a test
tube equipped with a screw cap, followed by drying up to harden in
a tube evaporator. The residue was dissolved in 20 .mu.l of
ion-exchanged water, and then 80 .mu.l of the ABME reagent was
added thereto, followed by reacting at 80.degree. C. for 45
minutes. After the reaction was ended, the reactant liquid was
dried up to harden under a nitrogen gas stream, followed by adding
2 ml of ion-exchanged water and 2 ml of diethyl ether thereto, and
then stirring. The resultant was centrifuged and an ether layer
containing unreacted ABME was removed. This ether extraction was
repeated five times, and the obtained aqueous layer was dried up to
harden in a tube evaporator to obtain a saccharide derivatized with
ABME. This saccaride was dissolved in 2 ml of high-purity water to
perform HPLC analysis.
[0163] A column used for HPLC analysis was Wakosil 5C18-200
(4.0.times.250 mm; manufactured by Wako Pure Chemical Industries,
Ltd.), the column temperature was 40.degree. C., the flowing rate
was 0.5 mL/min, and solvents used were a mixture composed of 5%
acetonitrile and 0.1M acetic acid solution (solvent A), and a
mixture composed of 15% acetonitrile and 0.1M acetic acid solution
(solvent B). Elution was performed in a solvent ratio A:B of 100:0
for 20 minutes after the sample was injected, and then elution was
performed in such a linear solvent's concentration gradient manner
that the solvent ratio A:B was changed to 0:100 over 80 minutes. UV
detection wavelength was 304 nm.
[0164] As a result, galactose, mannose, arabinose, rhamnose, and
N-acetylglucosamine were detected from the purified enzyme 1
derived from the product cultivated in a liquid state, but glucose
was not detected therefrom. On the other hand, mannose and
N-acetylglucosamine were detected from the purified enzyme 2
derived from the product cultivated with bran, but glucose,
galactose, arabinose, and rhamnose were not detected therefrom. In
addition, the sugar content of each purified enzyme is shown in
Table 1.
TABLE-US-00001 TABLE 1 Galactose Glucose Mannose Arabinose Xylose
Rhamnose N-acetylglucosamine Purified Enzyme 1 11.9 ND 1.72 29.0 ND
1.72 0.434 (derived from liquid-cultivated wild strain) Purified
Enzyme 2 ND ND 0.269 ND ND ND 0.045 (derived from bran-cultivated
wild strain) Purified Enzyme 5 0.046 ND 0.072 ND MD ND 0.015
(derived from recombinant mold) Purified Enzyme 6 ND 0.273 0.644 ND
ND ND 0.023 (derived from recombinant yeast)
Example 8
Quality Examination of Coenzyme-Linked Glucose Dehydrogenase
[0165] The purified enzymes 1 to 6, isolated in the above-mentioned
Examples 1 to 5, were examined in terms of activity, substrate
selectivity, inhibitor and coenzyme thereof. The enzyme activity
was measuremed in accordance with methods disclosed as Enzyme
activity measurement method-1 and Enzyme activity measurement
method-2 on pages 36 and 37 of the specification of
WO2004/058958.
1) Activity
[0166] Each purified enzyme was reacted with 500 mM D-glucose in
the presence of 8.66 mM DCIP, and the resultant was subjected to
quantitative analysis using a kit for D-gluconic
acid/D-glucono-.delta.-lactone quantitative analysis (manufactured
by Roche Diagnostics K.K.). As a result, it was confirmed that
D-gluconic acid was produced in each purified enzyme, and thus it
was revealed that the purified enzymes 2 to 6 were also enzymes
which catalyze a reaction in which a hydroxyl group at the
1-position of D-glucose was oxidized in the same way as the
purified enzyme 1.
2) Optimum pH:
[0167] The enzyme activity of the purified enzyme at various pH
regions was measured in a similar way to Enzyme activity
measurement method 2 except that a potassium phosphate buffer (pH
6.0 to 7.0), Tris-hydrochloride buffer (pH 7.4 to 8.0), or
glycine-sodium hydroxide buffer (pH 8.6 to 9.1) (each buffer being
used at the final concentration of 17 mM) was suitably used instead
of a buffer used in the measurement method 2. As a result, the
optimum pH of the purified enzymes 4, 5, and 6 was 7.0 to 9.0.
3) Stable pH
[0168] The purified enzyme was dissolved in 50 mM of each buffer,
that is, acetic acid/sodium acetate buffer (pH 3.6 to 5.3),
potassium phosphate buffer (pH 6.0 to 6.8), Tris-hydrochloride
buffer (pH 7.7), or glycine-sodium hydroxide buffer (pH 8.6 to
10.0), and then held at 40.degree. C. for 60 minutes, followed by
measuring the enzyme activity in accordance with the activity
measurement method-1 to analyze the residual rate of the enzyme
activity. The stable pH of the purified enzyme 5 was 4.5 to
8.5.
4) Optimum Temperature
[0169] The coenzyme-linked glucose dehydrogenase was dissolved in
50 mM potassium phosphate buffer (pH 7.0), and then the enzyme
activity in the temperature region between 30.degree. C. and
62.degree. C. was measured in accordance with the activity
measurement method-1. As a result, the optimum temperature of the
purified enzyme 5 was approximately 55.degree. C.
5) Temperature Stability
[0170] The coenzyme-linked glucose dehydrogenase was dissolved in
50 mM potassium phosphate buffer (pH 7.0), and then held for 15
minutes at a temperature within the range of 0.degree. C. to
55.degree. C., followed by measuring the enzyme activity in
accordance with the activity measurement method-1 to analyze the
residual rate of the enzyme activity. The residual rate of the
enzyme activity was calculated with respect to the enzyme activity
exhibited when held at 0.degree. C. for 15 minutes which is assumed
to be 100%. As a result, 89% of the enzyme activity of the purified
enzyme 5 was sustained even at 50.degree. C., and the enzyme
activity was stable at approximately 50.degree. C. or lower.
6) Subunit Molecular Weight:
[0171] The purified enzyme was subjected to SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) using 12.5% polyacrylamide gel in
accordance with a method disclosed by Laemmli et al., (Nature
(1970) 227: 680-685). After the electrophoresis was ended, the gel
was stained with Coomassie Brilliant Blue (CBB), and the mobility
of the enzyme was compared with that of a molecular weight marker
(LMW Marker; manufactured by Amersham Pharmacia Biotech, Inc.), as
a result of which it was revealed that the subunit molecular weight
of each enzyme was as follows: the subunit molecular weight of the
purified enzyme 2 was approximately 71 kDa, that of the purified
enzyme 4 was approximately 58 kDa, that of the purified enzyme 5
was approximately 81 kDa, and that of the purified enzyme 6 was
approximately 128 kDa.
7) Substrate Selectivity
[0172] The enzyme activity of the purified enzymes 1 to 6 was
measured in a similar way to the enzyme activity measurement
method-1 except that D-glucose or each other substrate (each being
used at the final concentration of 333 mM, excepting D-cellobiose
being used at the final concentration of 193 mM, and D-trehalose
and D-raffinose being used at the final concentration of 121 mM)
was used instead of the substrate in the reaction liquid for
measuring the activity by the activity measurement method-1. The
activity against each substrate was calculated as a relative value
with respect to the activity against D-glucose which is assumed to
be 100%.
[0173] The enzyme activity was measured in a similar way to the
above except that D-glucose was used at the final concentrations of
550 mM and 100 mM and maltose was used at the final concentrations
of 550 mM and 100 mM, and then the relative activity (enzyme
activity) thereof was determined. The activity toward maltose was
calculated as a relative value with respect to the activity toward
D-glucose.
[0174] In the same way as that of the purified enzyme 1, the
purified enzymes 2 to 6 according to the present invention strongly
acted on D-glucose, but weakly acted on D-mannose,
1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose,
D-galactose, D-glucose-6-phosphate, and D-fructose. The purified
enzymes 2 to 6 provided almost no action on L-arabinose, lactose,
D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose,
D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol,
and glycerol.
8) Inhibitor
[0175] To the reaction system in the activity measurement method-1,
1,10-phenanthroline dissolved in methanol so that each final
concentration was 1 mM, 5 mM, 10 mM, 25 mM, or 50 mM, was added,
followed by measuring the activity of the purified enzymes 1 to 6
by the activity measurement method-1. Each final concentration of
methanol in the reaction system was 10% (v/v). As a control,
methanol was added to the reaction system in the activity
measurement method-1 at the final concentration of 10% (v/v), and
then the activity was measured by the activity measurement
method-1. As a result, each inhibition ratio realized by
1,10-phenanthroline formulated at the final concentration of 1 mM
or more was 60% or more, which was high.
9) Coenzyme
[0176] D-glucose was added to the purified enzymes 1 to 6, and then
absorption spectrometry was performed. In each case, the absorption
maximums recognized at 385 nm and 465 nm disappeared by adding
D-glucose, and thus it was revealed that a coenzyme thereof was
FAD. The absorption maximums are specific to FAD, and cannot be
recognized in a control reaction system in which only FAD is not
contained.
Example 9
Comparison of Sensor Characteristics
[0177] Each bimolecular reaction rate constant of the purified
enzyme 1 prepared in the paragraph 1-2 of Example 1 and the
purified enzymes 4 to 6 prepared in Examples 3 to 5 was determined
using an electrochemical analyzer of CHI611A (manufactured by BAS
Inc.). A platinum auxiliary electrode, a carbon work electrode, and
a silver/silver chloride reference electrode were used. To MOPS
buffer with pH of 7.0, 142 mM of glucose, and any one of 0.45 .mu.M
of the purified enzyme 4, 0.76 .mu.M of the purified enzyme 5, 1.9
.mu.M of the purified enzyme 6, and 1.1 .mu.M of the purified
enzyme 1 were added, each concentration indicating the final
concentration, followed by adding an osmium complex
[Os(4-methyl-imidazole).sub.2(4-dimethyl-bipyridine).sub.2](PF.sub.6).sub-
.2 at the final concentration of 0 mM to 0.57 mM, and then
recording a cyclic voltammogram at each concentration (see FIG. 4).
As a result, it was revealed that the bimolecular reaction rate
constant of the purified enzyme 4 was 8.15.times.10.sup.4
s.sup.-1M.sup.-1, the bimolecular reaction rate constant of the
purified enzyme 5 was 7.36.times.10.sup.4 s.sup.-1M.sup.-1, and the
bimolecular reaction rate constant of the purified enzyme 6 was
9.38.times.10.sup.4 s.sup.-1M.sup.-1. The purified enzyme 1
provided so low a current that the steady current value could not
be found, and therefore, the bimolecular reaction rate constant
could not be calculated (FIG. 4).
[0178] In the same way, 142 mM of glucose, and any one of 0.45
.mu.M of the purified enzyme 4, 0.76 .mu.M of the purified enzyme
5, 0.55 .mu.M of the purified enzyme 6, and 1.1 .mu.M of the
purified enzyme 1 were added to MOPS buffer with pH of 7.0, each
concentration indicating the final concentration, followed by
adding a quinone compound, 2,3-dimethoxy-5-methyl-1,4-benzoquinone,
at the final concentration of 0 mM to 0.22 mM, and then recording
cyclic voltammogram at each concentration (see FIG. 5). As a
result, it was revealed that the bimolecular reaction rate constant
of the purified enzyme 4 was 1.14.times.10.sup.8 s.sup.-1M.sup.-1,
the bimolecular reaction rate constant of the purified enzyme 5 was
5.29.times.10.sup.7 s.sup.-1M.sup.-1, and the bimolecular reaction
rate constant of the purified enzyme 6 was 2.49.times.10.sup.7
s.sup.-1M.sup.-1. The purified enzyme 1 provided a low bimolecular
reaction rate constant of 5.69.times.10.sup.4 s.sup.-1M.sup.-1.
[0179] The results show that the enzymes derived from genetically
engineered cells exhibited improved reactivity in comparison with
the enzyme derived from a wild strain.
[0180] Each bimolecular reaction rate constant of the purified
enzymes 1 and 2 prepared in the paragraphs 1-2 and 1-3 of Example 1
was determined using an electrochemical analyzer of CHI611A
(manufactured by BAS Inc.). A platinum auxiliary electrode, a
carbon work electrode, and a silver/silver chloride reference
electrode were used. 142 mM of glucose and either 0.94 .mu.M of the
purified enzyme 1 or 3.3 .mu.M of the purified enzyme 2 were added
to MOPS buffer with pH of 7.0, each concentration indicating the
final concentration, followed by adding potassium ferricyanide at
the final concentration of 0 mM to 0.671 mM, and then recording a
cyclic voltammogram at each potassium ferricyanide concentration
(0, 0.019, 0.048, 0.095, 0.142, 0.188, 0.234, 0.280, 0.325, 0.370,
0.414, 0.458, 0.501, 0.544, 0.587, 0.629, and 0.671 mM). As a
result, it was revealed that the bimolecular reaction rate constant
of the purified enzyme 2 was 2.84.times.10.sup.3 s.sup.-1M.sup.-1.
The purified enzyme 1 provided so low a current that the steady
current value could not be found, and therefore, the bimolecular
reaction rate constant could not be calculated. It was assumed that
the purified enzyme 1 exhibited low reactivity because it was a
sugar-embedded type enzyme, while the purified enzyme 2 exhibited
improved reactivity because it was an enzyme with normal sugar
chains.
Example 10
Measurement of Glucose Using Enzyme-Immobilized Electrode
[0181] The concentration of D-glucose was measured by an
enzyme-immobilized electrode using each purified enzymes 1, 2, 4,
5, and 6. The current value in response to the glucose
concentration was measured using a glassy carbon (GC) electrode in
which 1.0 U of each enzyme was immobilized. 1.8 ml of 50 mM sodium
phosphate buffer (pH 7.0) and 0.2 ml of 1M potassium
hexacyanoferrate (III) (potassium ferricyanide) aqueous solution
were put into an electrolysis cell. After the GC electrode was
connected to a potentiostat of BAS100B/W (manufactured by BAS), the
solution was stirred at 40.degree. C. and the voltage of +550 mV
was applied to a silver/silver chloride reference electrode. To
this system, 20 .mu.l of 1M D-glucose solution was added and the
current value at the steady-state was measured. In addition, the
procedure in which the same amount of 1M D-glucose solution was
added and then the current value was measured was repeated three
times. The measured current values were plotted against the known
glucose concentrations (approximately 10, 20, 30, and 40 mM) to
generate each standard curve (FIG. 6). Thus, it was demonstrated
that quantitative analysis of glucose can be realized by the
enzyme-immobilized electrode using the GLD according to the present
invention.
Example 11
[0182] Plural oligonucleotides were synthesized based on the
sequence information set forth in SEQ ID NO. 1, and then
oligonucleotides set forth in SEQ ID NO. 13 and SEQ ID NO. 14 were
finally selected as a primer set. PCR was performed using the
primer set and a template DNA derived from each strain with an
ability of yielding the coenzyme-linked glucose dehydrogenase of
which a coenzyme is FAD, that is, Aspergillus japonicus IFO4408,
Penicillium cyaneum IFO5337, and Ganoderma applanatum IFO6498. The
template DNA was prepared by cultivating each strain in accordance
with the method described in Example 1 to obtain wet fungus bodies,
freezing the wet fungus bodies with liquid nitrogen, crushing the
fungus bodies, and then extracting with a mixture of
phenol/chloroform/isoamyl alcohol (25:24:1) (manufactured by NIPPON
GENE CO., LTD.). PCR was performed in 35 cycles of (94.degree. C.
for 30 seconds, 42.degree. C. for 30 seconds, and then 72.degree.
C. for 1.5 minutes) using TaKaRa LA Taq (manufactured by TAKARA BIO
INC.) and a thermal cycler (manufactured by Stratagene Corp.). Each
sequence of amplified products with a length of approximately 1.6
kbp was analyzed. The cDNA sequence free from introns was compared
with the sequence set forth in SEQ ID NO. 1 and sequences of a
known glucose oxidase and sorbose dehydrogenase. As a result, it
was revealed that nucleotide sequences (set forth in SEQ ID NOs. 5
to 7) and amino acid sequences (set forth in SEQ ID NOs. 8 to 12)
are specific to the coenzyme-linked glucose dehydrogenase of which
a coenzyme is FAD. In particular, it is assumed that the amino acid
sequence set forth in SEQ ID NO. 8 is a binding site of FAD and is
a portion of the active center.
INDUSTRIAL APPLICABILITY
[0183] The present invention can be utilized in a field of
examination of diabetes.
Sequence CWU 1
1
1411779DNAAspergillus terreus 1atgttgggaa agctctcctt cctcagtgcc
ctgtccctgg cagtggcggc acctttgtcc 60aactccacgt ccgccaaata tgattatatc
gttattggag gcggtactag cggtttggcc 120gtcgcaaacc gtctatcgga
ggatccaaac gtgaacgtac tcattctgga ggccggtggc 180tcggtctgga
acaatcccaa tgtcacaaac gtggatggct acgggcttgc ttttgggtct
240gacattgact ggcaatacca gtccgtcaac cagccatatg gaggcaacct
tagtcaagtg 300cttcgtgccg gcaaggccct tggtggtact agtactatca
atggcatggc ctatacgcgc 360gccgaggatg tccagatcga cgcctgggaa
accattggca acacaggatg gacgtggaag 420aatctgttcc cttactatcg
gaagagcgag aactttactg tccctaccaa atcgcagacc 480tctcttggag
cgtcgtatga agctggagcc cacggccacg agggtcccct tgacgttgcc
540ttcactcaga tcgagtcgaa caacctgacc acttacctca accgtacctt
ccagggcatg 600ggactcccat ggacggagga cgtcaatggc ggaaagatgc
gcggctttaa cttatacccc 660tccaccgtga atcttgagga gtatgtgcgc
gaagacgccg ctcgtgcata ctactggccc 720tacaagtccc gtcccaactt
gcatgtcctg ctcaacactt ttgccaaccg gattgtgtgg 780gacggcgaag
cccatgacgg ccacatcact gccagtggtg tcgagatcac ttccaggaac
840ggcactgttc gtgttatcaa tgcggagaag gaagtcattg tctctgccgg
tgccttgaag 900tccccggcta tccttgaact ttctggaatt ggcaacccta
gcgttcttga caagcacaac 960atccccgtca aggtcaacct cccgactgtc
ggcgagaacc ttcaggacca agtgaacagc 1020cacatggatg catcgggcaa
cacttccatc tctggaacca aggcagtctc ctaccccgat 1080gtctatgacg
tcttcggtga cgaagccgag tcggtcgcca aacagatccg tgccaacctg
1140aagcaatacg ccgccgacac cgccaaggcc aacggaaaca ttatgaaggc
cgccgatctg 1200gagcgtctct tcgaggtcca gtatgacctt attttcaagg
gcagagttcc aatcgctgaa 1260gtcctgaact atccgggcag cgcgacgtcc
gtgtttgcag aattctgggc cctccttccc 1320ttcgctcgtg gaagtgttca
catcggttct tcaaacccgg ccgagttccc tgtcatcaac 1380cccaactatt
tcatgctcga ctgggacgcg aagagctacg ttgccgttgc gaagtatatc
1440cgccgttcgt tcgagagcta ccctctcagc agtatcgtga aggagtctac
ccctggctat 1500gatgttatcc cccggaacgc ttctgagcag agctggaaag
aatgggtctt tgataagaac 1560tatcgttcta acttccatcc cgtcggcacg
gctgccatga tgcctcgtga gattggtggt 1620gtcgtggacg agcgtctgaa
tgtctatggc actacgaatg tcagagttgt agatgcttcg 1680gtccttccat
tccaggtctg cggccatttg gtgagcacac tatacgctgt ggccgaacgg
1740gcggcggatc tcatcaaggc cgatgctggt cgtcgttag
17792592PRTAspergillus terreus 2Met Leu Gly Lys Leu Ser Phe Leu Ser
Ala Leu Ser Leu Ala Val Ala 1 5 10 15 Ala Pro Leu Ser Asn Ser Thr
Ser Ala Lys Tyr Asp Tyr Ile Val Ile 20 25 30 Gly Gly Gly Thr Ser
Gly Leu Ala Val Ala Asn Arg Leu Ser Glu Asp 35 40 45 Pro Asn Val
Asn Val Leu Ile Leu Glu Ala Gly Gly Ser Val Trp Asn 50 55 60 Asn
Pro Asn Val Thr Asn Val Asp Gly Tyr Gly Leu Ala Phe Gly Ser 65 70
75 80 Asp Ile Asp Trp Gln Tyr Gln Ser Val Asn Gln Pro Tyr Gly Gly
Asn 85 90 95 Leu Ser Gln Val Leu Arg Ala Gly Lys Ala Leu Gly Gly
Thr Ser Thr 100 105 110 Ile Asn Gly Met Ala Tyr Thr Arg Ala Glu Asp
Val Gln Ile Asp Ala 115 120 125 Trp Glu Thr Ile Gly Asn Thr Gly Trp
Thr Trp Lys Asn Leu Phe Pro 130 135 140 Tyr Tyr Arg Lys Ser Glu Asn
Phe Thr Val Pro Thr Lys Ser Gln Thr 145 150 155 160 Ser Leu Gly Ala
Ser Tyr Glu Ala Gly Ala His Gly His Glu Gly Pro 165 170 175 Leu Asp
Val Ala Phe Thr Gln Ile Glu Ser Asn Asn Leu Thr Thr Tyr 180 185 190
Leu Asn Arg Thr Phe Gln Gly Met Gly Leu Pro Trp Thr Glu Asp Val 195
200 205 Asn Gly Gly Lys Met Arg Gly Phe Asn Leu Tyr Pro Ser Thr Val
Asn 210 215 220 Leu Glu Glu Tyr Val Arg Glu Asp Ala Ala Arg Ala Tyr
Tyr Trp Pro 225 230 235 240 Tyr Lys Ser Arg Pro Asn Leu His Val Leu
Leu Asn Thr Phe Ala Asn 245 250 255 Arg Ile Val Trp Asp Gly Glu Ala
His Asp Gly His Ile Thr Ala Ser 260 265 270 Gly Val Glu Ile Thr Ser
Arg Asn Gly Thr Val Arg Val Ile Asn Ala 275 280 285 Glu Lys Glu Val
Ile Val Ser Ala Gly Ala Leu Lys Ser Pro Ala Ile 290 295 300 Leu Glu
Leu Ser Gly Ile Gly Asn Pro Ser Val Leu Asp Lys His Asn 305 310 315
320 Ile Pro Val Lys Val Asn Leu Pro Thr Val Gly Glu Asn Leu Gln Asp
325 330 335 Gln Val Asn Ser His Met Asp Ala Ser Gly Asn Thr Ser Ile
Ser Gly 340 345 350 Thr Lys Ala Val Ser Tyr Pro Asp Val Tyr Asp Val
Phe Gly Asp Glu 355 360 365 Ala Glu Ser Val Ala Lys Gln Ile Arg Ala
Asn Leu Lys Gln Tyr Ala 370 375 380 Ala Asp Thr Ala Lys Ala Asn Gly
Asn Ile Met Lys Ala Ala Asp Leu 385 390 395 400 Glu Arg Leu Phe Glu
Val Gln Tyr Asp Leu Ile Phe Lys Gly Arg Val 405 410 415 Pro Ile Ala
Glu Val Leu Asn Tyr Pro Gly Ser Ala Thr Ser Val Phe 420 425 430 Ala
Glu Phe Trp Ala Leu Leu Pro Phe Ala Arg Gly Ser Val His Ile 435 440
445 Gly Ser Ser Asn Pro Ala Glu Phe Pro Val Ile Asn Pro Asn Tyr Phe
450 455 460 Met Leu Asp Trp Asp Ala Lys Ser Tyr Val Ala Val Ala Lys
Tyr Ile 465 470 475 480 Arg Arg Ser Phe Glu Ser Tyr Pro Leu Ser Ser
Ile Val Lys Glu Ser 485 490 495 Thr Pro Gly Tyr Asp Val Ile Pro Arg
Asn Ala Ser Glu Gln Ser Trp 500 505 510 Lys Glu Trp Val Phe Asp Lys
Asn Tyr Arg Ser Asn Phe His Pro Val 515 520 525 Gly Thr Ala Ala Met
Met Pro Arg Glu Ile Gly Gly Val Val Asp Glu 530 535 540 Arg Leu Asn
Val Tyr Gly Thr Thr Asn Val Arg Val Val Asp Ala Ser 545 550 555 560
Val Leu Pro Phe Gln Val Cys Gly His Leu Val Ser Thr Leu Tyr Ala 565
570 575 Val Ala Glu Arg Ala Ala Asp Leu Ile Lys Ala Asp Ala Gly Arg
Arg 580 585 590 332DNAArtificial SequenceDescription of Artificial
Sequence Synthetic oligonucleotide 3cgtcatggta cctccaactc
cacgtccgcc aa 32432DNAArtificial SequenceDescription of Artificial
Sequence Synthetic oligonucleotide 4agtgtactgc agctaacgac
gaccagcatc gg 325214DNAAspergillus terreusmodified_base(14)..(14)a,
c, t or g 5tbgargcmgg hgvntcngbn ydsaacaayy ysraygtvwc naaysyndhb
ggytayrgvh 60yngcnttygg vwcbsmbrty gaytggsmvt aymarwcbrw baaccarmvv
taygsaggmr 120rymwdmvbca rrybhtncgw gcbgghaarg yymtbggwgg
nacbagyacn atcaatggma 180tgkcmtayac bcgvgcmsar gaygtbcara tyga
214688DNAAspergillus terreusmodified_base(71)..(71)a, c, t or g
6tyctygarct ktchgghrtk ggmaacccdd ssvtyytbra mraghacaay atmhcmsymv
60ddgtyraymt nmcvacygty ggvgaraa 887209DNAAspergillus
terreusmodified_base(27)..(27)a, c, t or g 7atcaayccha actaytwyat
gytygrnyrr gayrbbrmrd shyavryyrs bryhgcsmar 60twyatymgsh vbdybytbsr
baaykmnccw ytbwvcdvwh tyrtkrvvdm kkmdryyhmb 120ssykrhbwbd
hyrhvvyhys drmyrvtkch dmsvrbdvsd vdwrrdhhdr dkksbtyrad
180rmdrmytayc gwwchaactw ccayccmgt 209815PRTAspergillus
terreusMOD_RES(2)..(2)Ala or Gly 8Gly Xaa Gly Thr Ser Gly Leu Xaa
Xaa Ala Asn Arg Leu Ser Glu 1 5 10 15 926PRTAspergillus
terreusMOD_RES(5)..(5)Ala or Val 9Arg Ala Gly Lys Xaa Xaa Gly Gly
Thr Ser Thr Ile Asn Gly Met Xaa 1 5 10 15 Tyr Thr Arg Ala Xaa Asp
Val Gln Ile Asp 20 25 1013PRTAspergillus terreusMOD_RES(3)..(3)Ala
or Leu 10Ser Pro Xaa Xaa Leu Glu Leu Ser Gly Xaa Gly Asn Pro 1 5 10
117PRTAspergillus terreus 11Thr Val Gly Glu Asn Leu Gln 1 5
1211PRTAspergillus terreusMOD_RES(5)..(5)Ala or Ser 12Leu Leu Pro
Phe Xaa Arg Gly Xaa Xaa His Ile 1 5 10 1319DNAAspergillus terreus
13ttggwggygg wacyagtgg 191420DNAAspergillus terreus 14gtkcckacgg
gatggaagtt 20
* * * * *